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Abstract
Improving the nutritional status of hospitalized patients has been shown to reduce length
of stay (LOS), hospital costs, readmission rates, complication rates, and mortality.
Provision of nutrient-rich, liquid, oral nutrition supplements (ONS) is one approach to
improving nutritional status. ONS use has been associated with improved outcomes
among patients with diagnoses of orthopedic injuries and pressure ulcers, mainly using
prospective designs among elderly and/or malnourished patients. Less information is
available for other diagnoses, and no analysis of the effects of ONS could be found that
considered the epidemiological triad of person, place, and time. This study used a
quantitative, retrospective design to examine whether routine ONS use was associated
with hospital length of stay (LOS) among 570 adult inpatients at a regional medical
center diagnosed with heart failure, adjusting for significant personal, locational, and time
variables. It was unique in the inclusion of epidemiological triad variables. Using
multiple logistic regression to control for covariates, ONS use was associated with higher
LOS in this sample (odds ratio=2.43). High LOS was also associated with higher
Charlson Comorbidity Index (CCI) values, discharge destination, White ethnicity, female
gender, and hospital room location. This study is expected to contribute to positive social
change by helping inform hospital staff on factors affecting patient outcomes and LOS,
and highlighting the need for continued research on interventions to improve care in
hospitals.
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Chapter 1: Introduction to the Study
Introduction
Nutrition intervention in acute care hospitals has been shown to be associated
with improved medical status and outcomes for patients, leading to reduced length of stay
(LOS) and reduced readmission rates in hospitals (Gariballa S, Forster S, Walters S,
Powers, 2007; Hoekstra, Goosen, de Wolf, & Verheyen, 2011; Lawson, Dishi, Barton, &
Cobden, 2003; Somanchi, Tao, & Mullin, 2011). Nutrition intervention often includes
consultation of registered dietitians (RDs), who determine best approaches to address
patients’ nutritional problems. One common approach used by dietitians and medical
providers is commercial, nutrient-rich, liquid ONS. Improved outcomes among patients
receiving ONS have previously been demonstrated among patients with orthopedic
injuries or pressure ulcers (Botella-Carretero et al., 2008, 2010; Bourdel-Marchasson et
al., 2000; Lawson et al., 2003; Miller, Crotty, Whitehead, Bannerman, & Daniels, 2006).
Much of the evidence for improved outcomes has involved elderly patients (ArnaudBattandier et al., 2004; Bourdel-Marchasson et al., 2000; Gariballa et al., 2007; Hoekstra
et al., 2011; Neelemaat, Bosmans, Thijs, Seidell, & van Bokhorst-de van der Schueren,
2012) or elderly malnourished patients (Arnaud-Battandier et al., 2004; Neelemaat et al.,
2012).
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This study examined patient and hospital outcomes among patients aged 18 and
over receiving ONS compared to patients not receiving this intervention at a regional
medical center in the southeastern United States. The study was limited to patients with a
diagnosis of heart failure (HF). I originally planned to examine one hospital outcome
(LOS) and two patient outcomes (changes in albumin levels and weight changes). In the
final analysis, I was only able to examine the LOS outcome. While investigating
outcomes, I controlled for and evaluated the confounding effects of body mass index
(BMI), age, gender, initial albumin levels, B-type natriuretic peptide (BNP) levels,
Charlson Comorbidity Index (CCI), diagnosis of malnutrition, location in the hospital,
and time of year of admission.
This study has the potential to promote positive social change by examining
aspects of patient care in hospitals that can improve patient health and quality of life,
while evaluating potentially more efficient ways to use patient, hospital, and community
resources. Use of ONS and other nutrition interventions, such as dietitian consultations,
have been shown in other studies to improve the healing process, prevent complications,
and reduce the time patients spend in the hospital. This study helps clarify the role of
ONS use and RD consultations in normal hospital care, and how these are related to LOS.
Shortened LOS can benefit patients, their families, and hospitals. It can reduce costs of
hospital care.
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This chapter includes an overview of the study topic, background of the study,
and a summary of the relevant literature. A more detailed literature review is presented in
Chapter 2. The research problem, independent and dependent variables, research
questions, and hypotheses are reviewed. In addition, the theoretical foundation and
conceptual framework are introduced, with a more detailed description in Chapter 2.
Definitions of key variables are provided, followed by a discussion of the assumptions,
scope, limitations, delimitations, and significance of the problem.
Background
Malnutrition among hospitalized patients has been shown to adversely affect
individual health outcomes and has been associated with increased hospital LOS and
readmissions (Correia & Waitzberg, 2003; Lim et al., 2012; Agarwal et al., 2013). It has
been estimated that malnutrition in acute care hospital patients affects from 30-55% of
hospital patients worldwide (Agarwal et al., 2012; Barker, Gout, & Crowe, 2011;
Somanchi et al, 2011), with some studies finding malnutrition rates of up to 69% in
hospitals (Singh, Watt, Veitch, Cantor, & Duerksen, 2006; Young, Kidston, Banks,
Mudge, & Isenring, 2013). Research has demonstrated that the prevention and treatment
of malnutrition in hospital patients reduces cost of care, LOS, readmission rates,
mortality, and complication rates among patients (Correia & Waitzberg, 2003; Somanchi
et al., 2011; Rasheed & Woods, 2013, Tappenden et al., 2013). Aziz et al. (2011) found a
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significant association between LOS and lower nutrition risk scores among HF patients,
using a risk score derived from albumin levels and weight changes.
Several types of interventions have been demonstrated to improve the nutritional
or clinical status of patients, or to reduce rates of malnutrition in hospitals. One approach
that has shown success in improving clinical outcomes is nutrition intervention by
clinical nutrition staff (Hoekstra et al., 2011; Neelemaat et al., 2012; Somanchi et al.,
2011). Another approach, often combined with clinical staff intervention, is the provision
of nutrient-rich ONS).
A number of researchers in recent years have looked at the use of ONS to
improve nutrition-related outcomes in a variety of settings. Arnaud-Battandier et al.
(2003) found that ONS improved the nutritional status of elderly patients in a community
setting, leading to reduced health care costs. Significantly reduced costs for additional
treatments were demonstrated through administration of ONS to all postoperative
orthopedic patients in another study (Lawson et al., 2003). Miller et al. (2006) found that
ONS appeared to be beneficial in preventing weight loss following lower limb fractures;
Botella-Carretero et al. (2010) found improved postoperative recovery and smaller drops
in serum albumin among hip fracture patients receiving supplements, and Lawson et al.
(2003) found fewer complications among orthopedic patients using supplements
compared to a control group. Bourdel-Marchasson et al. (2000) found lower risk of
pressure ulcer development among patients using ONS. Gariballa, Forster, Walters, and
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Powers (2006) showed shorter LOS among elderly hospitalized patients receiving ONS,
as well as lower risk of mortality and hospital readmission, and improved nutritional
status. Neelemaat et al. (2012) showed smaller decreases in functional limitations of
hospitalized patients getting ONS. Stratton and Elia (2007) performed a meta-analysis to
demonstrate consistent clinical benefits—such as improved nutritional status and
reductions in complications—associated with the use of ONS in hospital and community
settings.
With recent changes in the American health care system and the Affordable Care
Act, hospitals are increasingly seeking ways to reduce health care costs. Hospitals also
continue to strive to improve patient clinical outcomes. Nutrition interventions have been
shown to reduce health care costs by improving clinical outcomes, complications, and
LOS; however, there are few studies on clinical interventions and ONS use in relation to
LOS and clinical outcomes. Among the studies of benefits of ONS, only one of the above
studies involved the effect of ONS on hospital LOS (Gariballa et al., 2006); and only one
involved clinical nutrition staff interventions in relation to LOS (Somanchi et al., 2011).
In addition, none of the reviewed studies evaluated the variables in terms of the
epidemiological triad of person, place, and time—factors that could shed further light on
how to maximize any benefits of ONS and other nutrition interventions. Therefore, more
research is needed on whether ONS use and/or clinical nutrition interventions are related
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to clinical and hospital outcomes, and whether there are personal factors, timing issues, or
location factors that influence these relationships.
Problem Statement
While there is abundant evidence that malnutrition, inadequate nutrition, or poor
nutritional status, have adverse consequences for hospitalized patients, less is known
about best strategies to improve nutritional status and outcomes for patients. In addition,
because hospitals have only a limited time period in which to address poor nutrition
among inpatients, there is a need for quick and efficient interventions.
Nutrition intervention by clinical staff has been shown in two studies to be an
effective approach to reduce malnutrition rates and improve patient and hospital
outcomes (Somanchi et al., 2011; Hoekstra, et al., 2011). Liquid ONS that contain
significant amounts of kilocalories (kcal), protein, and multiple nutrients, are often
provided as one component of such nutrition interventions because they are a simple and
efficient intervention to address the problem of inadequate intake and its adverse
outcomes.
The most available evidence in recent years showing improved outcomes related
to ONS use is among selected populations. This includes elderly patients (ArnaudBattandier et al., 2004; Botella-Carretero et al., 2010; Bourdel-Marchasson et al., 2000;
Neelemaat et al., 2012), orthopedic patients (Lawson et al., 2003)—especially those with
hip fractures (Botella-Carretero et al., 2010; Hoekstra et al., 2011), and pressure ulcers
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(Houwing, 2003). Evidence is limited, however, for other specific diagnostic categories,
such as acute myocardial infarction (AMI), heart failure (HF), chronic obstructive
pulmonary disease (COPD), and pneumonia. There is also evidence that interventions are
more pronounced among patients with poor nutritional status, as indicated by selected
nutritional indicators or tools (Philipson, Snider, Lakdawalla, Stryckman, & Goldman,
2013; Somanchi et al., 2011). Therefore, additional studies are needed to evaluate the
relationship between ONS use, patient and hospital outcomes, and factors that may be
influencing this relationship in hospitalized patients with HF.
Purpose of the Study
This study was intended to provide further insight into whether intervention with
ONS is related to improved outcomes in hospitalized patients with HF. Only one
dependent variable could ultimately be analyzed—LOS. Quantitative statistical analysis
was used to compare this outcome for patients who received ONS during the hospital stay
compared to patients who did not receive supplements, while controlling for and
evaluating effects of covariates known to affect nutritional status and LOS.
A manufacturer of a common ONS in the United States has recommended routine
ONS use for patients who meet certain criteria in hospitals, citing evidence that the use of
ONS in hospitals may be an effective and efficient way to improve patient and hospital
outcomes, reduce hospital LOS, and reduce readmission rates (Alliance to Advance
Patient Nutrition, 2013; Abbott Laboratories, 2014). One major study cited by the ONS
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manufacturer was a large 10-year retrospective study on ONS use and hospital outcomes
using data from the Premier Perspectives Database, in which the authors looked at
hospital outcomes in relation to 724,027 episodes of ONS use in the database of 44.0
million inpatient episodes (Philipson et al., 2013). This study was limited by the fact that
it was an administrative database; therefore, clinical data were unavailable. Gariballa et
al. (2006) found shorter LOS—9.4 versus 10.1 days, among acutely ill elderly patients
who received ONS compared to those who did not receive supplements. In another
clinical study, routine ONS provision for post-operative orthopedic patients was found to
be associated with a significantly lower rate of major complications, transferrin levels,
hemoglobin levels, and cost of additional treatments (Lawson et al., 2003).
My study is unique in its focus on the effectiveness of nutrition intervention using
ONS in a setting within the southeastern United States, with LOS, albumin, and weight
change as outcomes and/or indicators of clinical status. It focused on patients with HF, a
diagnosis that has not been adequately addressed in ONS intervention trials. The
retrospective quantitative design allowed for evaluation of the effectiveness of ONS use
in a setting that reflects day-to-day operations of an acute care hospital. The
epidemiological design included an examination of personal characteristics, location in
the hospital by hospital unit, and timing of the nutrition interventions in relation to date of
admission, time of year, and timing during the day.
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Research Questions and Hypotheses
For the following research questions and hypotheses, all participants were
hospitalized patients at the study facility, and all nutrition interventions were in relation
to this population.
Research Question 1: How is the provision of ONS related to changes in albumin
levels in participants over the course of hospitalization?
H01: Changes in patients' serum albumin levels will not be significantly different
between patients receiving ONS and those not receiving ONS during the course of
hospitalization after adjusting for baseline level of body mass index, age, race, gender,
BNP levels, season of the year, location in the hospital, weight changes, initial albumin
level, CCI, RD consultation, and diagnosis of malnutrition.
Ha1: Changes in patients' serum albumin levels will be significantly different
between patients receiving ONS and those not receiving ONS during the course of
hospitalization after adjusting for baseline level of body mass index, age, race, gender,
BNP levels, season of the year, location in the hospital, weight changes, initial albumin
level, CCI, nutrition risk screening score, RD consultation, and diagnosis of malnutrition.
Method of measurement: t-test derived from multiple linear regression analysis to
compare mean changes in albumin levels in patients receiving ONS with those not
receiving ONS.
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Research Question 2: How is the provision of ONS related to patient weight
changes during the course of hospitalization?
H02: Changes in patients' weights will not be significantly different between
patients receiving ONS and the those not receiving ONS after adjusting for baseline level
of body mass index, age, race, gender, BNP levels, season of the year, location in the
hospital, initial albumin level, CCI, RD consultation, and diagnosis of malnutrition.
Ha2: Changes in patients' weights will be significantly different between patients
receiving ONS and the those not receiving ONS during the course of hospitalization after
adjusting for baseline level of body mass index, age, race, gender, BNP levels, season of
the year, location in the hospital, weight changes, initial albumin level, CCI, RD
consultation, and diagnosis of malnutrition.
Method of measurement: t-test derived from multiple linear regression analysis
to compare mean weight change for patients receiving ONS with those not receiving
ONS.
Research Question 3: How is the provision of ONS related to patient LOS in the
hospital?
H03: There will be no statistically significant difference in the odds of high LOS
between patients receiving ONS and those not receiving ONS after adjusting for baseline
level of body mass index, age, race, gender, BNP levels, season of the year, location in
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the hospital, weight changes, initial albumin level, CCI, RD consultation, and diagnosis
of malnutrition.
Ha3: There will be a statistically significant difference in the odds of high LOS
between patients receiving ONS and those not receiving ONS after adjusting for baseline
level of body mass index, age, race, gender, BNP levels, season of the year, location in
the hospital, weight changes, initial albumin level, CCI, RD consultation, and diagnosis
of malnutrition.
Method of Measurement: Odds ratios determined from multiple logistic
regression analysis with ONS as the main predictor, controlling for covariates above
shown to be associated with LOS through two-way tables.
Theoretical Foundation
The theoretical framework for this paper was the epidemiological triad of person,
place, and time. Examination of the frequency of health-related events, along with
person, place, and time factors, provides the basis for descriptive epidemiology (Johns
Hopkins Bloomberg School of Public Health, 2008). Epidemiology is "the study of the
occurrence and distribution of health-related events, states, and processes in specified
populations, including the study of the determinants influencing such processes, and the
application of this knowledge to control relevant health problems" (Porta, 2014). In order
to evaluate patterns of health -related states in populations, an examination of how health
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events vary according to person, place, and time is required (Centers for Disease Control
and Prevention [CDC], 2012).).
This model was used by John Snow, a pioneer of modern epidemiological
methods, who investigated a cholera outbreak in London in 1853-54 (time) by evaluating
the geographic distribution of the outbreak (place), and found that only those people
using a particular water pump (place) developed cholera, regardless of sex, age, social
standing, occupation, or income status (person; Schneider, 2006). A more detailed
explanation and history of this theory, with further examples, may be found in Chapter 2.
In my study this theory provides a framework for a thorough investigation that
may uncover issues related to person place, and time that were not previously
appreciated. Covariates include person, place, and time factors. Personal factors include
age, body-mass index (BMI), and other health indicators; the place-related factor is
location in the hospital; and time-related factor involves an evaluation of the time of year
(by quarters) in which patients were admitted, and timing of nutrition intervention during
hospitalization.
Conceptual Framework
A key concept in this study is malnutrition, and its relationship to patient and
hospital outcomes. Malnutrition can be described as "the condition that develops when
the body does not get the right amount of the vitamins, minerals, and other nutrients it
needs to maintain healthy tissues and organ function" (Farlex, 2014). Malnutrition often
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has not been adequately recognized or addressed in hospitals (Tappenden et al., 2013);
nor has it been clearly or consistently defined in the hospital setting (Jensen, Bistrian,
Roubenoff, & Heimburger, 2009; White, Guenter, Jensen, Malone, & Schofield, 2012).
However, the value of recognizing and treating nutritionally compromised patients has
been recognized by The Joint Commission, whose standards require hospital patients to
be screened for high-risk nutritional status within 24 hours of admission (The Joint
Commission, 2012).
Definitions of Malnutrition
Malnutrition has been defined by several methods in previous studies on
nutritional status and nutritional interventions in hospitals. Some studies use predefined
tools, and others use only certain factors such as body mass index (BMI) and weight
changes (Neelemaat et al., 2012). One common tool is the Subjective Global Assessment
(SGA; Detsky et al., 1987). Factors included in the SGA include changes in weight,
dietary intake, gastrointestinal symptoms, functional capacity, disease, and subjective
rating by physical exam (Detsky et al., 1987). Another validated tool that is a very
abbreviated form of screening for malnutrition is the Malnutrition Screening Tool (MST),
developed by Ferguson, Capra, Bauer, and Banks (1999). It is based on patients’
perceptions of food intake in relation to appetite, and patient report of unplanned weight
loss (Ferguson et al., 1999). More detail on definitions of malnutrition in relation to
studies of ONS and RD interventions can be found in Chapter 2. Aziz et al. (2011) used
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the Nutrition Risk Score (NRS), which is calculated from serum albumin level and ratio
of actual to usual weight. A medical diagnosis of malnutrition is designated by ICD-9
codes 263.9 (Unspecified protein-calorie malnutrition), or 269.9 (Unspecified nutritional
deficiency).
Malnutrition and Patient and Hospital Outcomes
A number of studies have shown that malnutrition adversely affects individual
health outcomes and hospital outcomes (Correia & Waitzberg, 2003; Lim et al., 2012;
Agarwal et al., 2013, Chima et al., 1997). Outcomes related to malnutrition include cost
of hospitalization, hospital mortality, and LOS (Agarwal et al., 2013; Chima et al., 1997;
Correia & Waitzberg, 2003). In addition, several studies have also indicated that the use
of ONS and other nutrition interventions among hospitalized patients appear to have a
greater effect among sicker or more malnourished patients in comparison to wellnourished or healthier patients (Philipson et al., 2013; Somanchi et al., 2011).
Nature of the Study
A retrospective observational study design was used. This study was designed as
an epidemiological study rather than a clinical trial. The independent variable (IV) in this
study was nutrition intervention using ONS. Dependent variables included two clinical
outcomes (albumin and weight changes); and one hospital outcome (LOS). Covariates
included BMI, age, race, gender, BNP levels, season of the year, location in the hospital,
payer, CCI, RD consultation, diagnosis of malnutrition, and planned discharge
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destination. These covariates included the three aspects of the epidemiological triad:
person, place, and time.
Data were extracted by hospital information services staff from the electronic
medical records/healthcare information system at the hospital. Quantitative methods of
analysis were used to compare outcomes for hospital patients who received ONS with a
comparison group that did not receive supplements over a 2-1/2-year period. The
observational, retrospective, design allowed for evaluation of the effectiveness of
dietitian interventions and ONS use in a real-world setting that reflected day-to-day
operations in an acute care setting.
Definitions
Albumin: Albumin is the major protein found in the blood plasma (Serum albumin
test, n.d.). It has been associated with poor nutritional status and presence of disease. It
may be low when there is inadequate intake or absorption of nutrients, especially protein
(Serum albumin test, n.d.).
B-type natriuretic peptide: This is a cardiac hormone secreted from the heart in
response to volume and pressure overload (Faggiano et al., 2010; Mair, 2011). It is used
to diagnose or to rule out heart failure, as well as to indicate severity of HF (Faggiano et
al., 2010; Mair, 2011). A reduction in BNP has been associated with improved outcomes
and reduced risk of future adverse events (Dhaliwal et al., 2009; Di Somma et al., 2010;
Mair, 2011; Yancy et al., 2013).
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Body mass index: The BMI is a common general indicator of body fatness. It is
used as a screening tool to determine whether a person is underweight or overweight. It is
an indirect measure of body fat, so is not as reliable as direct measures such as
underwater weighing or skinfold thickness measurement; however, it is the easiest
method and based on readily available information—height and weight. The following
table from the CDC (2014) shows the ranges of BMI and how they are interpreted:
Below 18.5

Underweight

18.5 – 24.9

Normal

25.0 – 29.9

Overweight

30.0 and Above

Obese

Charlson Comorbidity Index: This is a comorbidity index with 17 items,
weighted according to association with mortality (Charlson, Pompei, Ales, & MacKenzie,
1987; Degroot, Beckerman, Lankhorst, & Bouter, 2003; Farley, Harley, & Devine, 2006).
A modified form with 19 items is also available (Rohrer, Adamson, Barnes, & Herman,
2008). Several studies have validated an adaption of the CCI using ICD-9 codes (Deyo,
Cherkin, & Ciol, 1992; Quan et al., 2005; Sundararajan et al., 2004). The study by Quan
et al. (2005) includes expanded ICD-9 codes to address inconsistencies in interpreting
CCI with ICD-9 codes, and to better align with the more detailed ICD-10 coding.
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Because of the availability of ICD-9 codes for all diagnoses on patients at the study
hospital and current transition to ICD-10 codes (October 2015), I used the CCI adaptation
by Quan et al. to control for severity of illness in this study.
The relationship between the index and ONS use was demonstrated by Philipson
et al. (2013) in their large retrospective study that used billing and diagnostic data from
the Premier Perspectives Database to show the impact of ONS use on hospital outcomes.
They found a significantly higher (p < .0001) mean CCI score of 3.4 for patients using
ONS (724,027 episodes), compared to a score of 2.1 for all hospitalization episodes (N =
43,244,540).
Length of Stay: This refers to the length of time in days that a person is
hospitalized. For this study, exact LOS was calculated using date and time of admission
and discharge.
Malnutrition: This term is defined in detail under the Conceptual Framework
section (above).
Nutritional Risk Screening Tool: At the time of this study, a nutritional risk
screening tool used at MRMC used to determine which patients are at high-risk
nutritionally and in need of dietitian consultations. Further information on this tool may
be found under Instrumentation and Operationalization of Constructs in Chapter 3.
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The tool contained criteria used by nurses to screen patients for nutritional risk
within 12 hours of admission and during shift assessments every 12 hours. It included the
following items: head/neck cancer with chemotherapy/radiation therapy; diagnosis of
malnutrition/failure to thrive; hyperemesis gravidarium; LOS >11 days; NPO (nil per os,
or nothing by mouth) or clear liquids diet >5 days; poor oral intake of 3 or more days;
stage 2-4 pressure sore, non-healing wound, or deep tissue injury; and unplanned weight
loss of >10 pounds in the past 3 months.
If a nurse checked off any one of these items during the initial nursing assessment
or 12-hour shift assessment for a patient at any time during the hospital stay, an automatic
referral was triggered for a registered dietitian consultation (see definition below). See
Appendix for a screenshot of the tool used by the nurses for nutrition screening.
ONS: Commercial oral liquid high-protein, high-calorie oral nutrition
supplements. For this study, I included only ONS ordered at least twice daily, with at
least 220 kcal per 8-ounce serving, at least 40% of calories from carbohydrate, at least
10% of calories from protein, and at least 20% of calories from fat; or one supplement
daily providing the same nutrients (and at least 440 kcal) in one serving.
Registered Dietitian (RD) Consultation: This refers to a request for the services of
a registered dietitian (RD), initiated by a physician order or nutritional screening (defined
above) trigger by a nurse.
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Assumptions
Supplement data were not consistently recorded in the electronic medical record
(EMR) from which the data was abstracted. Because the EMR did not have reliable data
on how much of the supplements were being consumed by patients, it was necessary to
assume that patients were consuming the supplements provided, which may not always
have been the case. However, staff at this facility have historically discontinued orders
for supplements if they were not being consumed.
It was assumed that LOS reflected duration of illness and severity of condition
while in the hospital, so an intervention that supported improved health outcomes would
be associated with shorter LOS. Patients who are sicker tend to have poorer oral intake
and may be more likely to be prescribed ONS (Philipson et al., 2013). However, an
attempt was made to minimize this bias by controlling for covariates known to influence
LOS.
Scope and Delimitations
This study focused on the adult (age 18 or over) inpatient population at a regional
acute care medical center with a diagnosis of heart failure (HF). This one diagnosis was
chosen after analysis of sample size showed that there may be inadequate data available
to analyze or control for other proposed diagnoses, including AMI, COPD, and
pneumonia.
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The use of ONS was selected because it has the potential to be a convenient, costeffective nutrition intervention to address inadequate nutrition in inpatient settings, in
light of the previously demonstrated importance of nutrition on patient and hospital
outcomes. Nutrition is a preventive factor that can be relatively easily addressed in the
hospital, and is a cost-effective way to improve outcomes (Neelemaat et al., 2012;
Philipson et al., 2013; Somanchi et al., 2011). While there is previous evidence of the
effectiveness of nutrition outcomes for wound outcomes and orthopedic injuries (BotellaCarretero et al., 2010; Hoekstra et al., 2011; Lawson et al., 2003; Miller et al., 2006;
Houwing, 2003), information is lacking on how nutrition interventions specifically affect
HF patient outcomes. In addition, HF is one of the diagnoses chosen by Medicare as
high-risk outcomes with frequent readmissions (Kociol et al., 2013); readmission rates
have also been demonstrated to be higher with diagnosis of HF (Aziz et al., 2011; Kociol
et al., 2013). Therefore, this study was limited to patients with this diagnosis.
Many studies have focused only on elderly patients, but because patients at any
age may need nutritional intervention, this study included all adults aged 18 and over.
Only patients exclusively on oral diets were considered, because of the confounding
effects of tube feedings or total parenteral nutrition. Patients on clear liquids were
excluded because of the baseline inadequacy of such diets. While there are potential
benefits to outpatients or patients living in the community (Arnaud-Battandier et al.,
2004), it was not practical for this dissertation study to include that population.
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It was expected that the results of this study could be generalizable to future HF
inpatients at the same hospital, as well as inpatients at other hospitals with the same
diagnoses. However, results could vary from hospital to hospital according to severity of
conditions in the facility, supplement protocols, demographic profiles of the patient
population, and other factors identified as covariates by the outcomes of this study.
Limitations
Based on my personal experience at this hospital, nutritional interventions were
addressed by one of several dietitians working in the facility, and different clinicians may
provide different intervention approaches; some may be more likely to order ONS than
others. However, it is expected that the mix of intervention approaches at this facility will
generally reflect the nutrition intervention approaches in other acute care facilities, unless
a specific policy is in place regarding the prescribing of ONS.
I attempted to control for any major known confounding variables, but not all
confounding factors can be identified because of the numerous factors affecting clinical
and hospital outcomes. For example, the lack of availability of an appropriate and safe
discharge facility may significantly delay discharge from the hospital. For this reason, the
study controlled for discharge destination (home, rehabilitation, or long-term care, or
death). Additionally, LOS is often a skewed (non-linear) variable (J. Rohrer, personal
communication, September 22, 2014), and this was true for this study. Therefore, highlow categories were used for this outcome, and logistic regression was used instead of
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linear regression to analyze the LOS outcome. Data from previous studies were used to
determine those other factors most likely to affect LOS.
Design and/or Methodological Weaknesses
Since this was a retrospective observational study, it did not have the strong
internal validity of a randomly controlled trial (RCT). However, observational studies
such as this one have an advantage over an RCT in that they can capture the results of
patterns of practice of the clinicians who normally provide these interventions in the
acute care setting (Hannan, 2008). This study may better reflect the realities and limits of
normal hospital operations, such as variation in patient loads and limited time to identify
and assess high-risk patients. RCTs also have weaker external validity than observational
studies; that is, they may not be as generalizable to populations outside of the sample
population (Hannan, 2008). This study sought to produce results that could apply to other
hospital settings and potentially other diagnoses.
Patients for whom supplements are ordered in the hospital are generally eating
more poorly and/or are sicker than patients for whom they are not prescribed (Philipson
et al., 2013). This potential weakness was addressed by controlling for factors known to
affect nutrition status and supplement use.
Patients with heart failure may have large amounts of fluid retention, so weights
may vary and some weight loss (sometimes quite large amounts) may be associated with
improvement in condition.
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Biases
The biggest potential bias may be that of selection bias; that is, patients who are
found to have received ONS or nutrition consultation would be those patients who were
considered at higher risk nutritionally by medical or nursing staff, or through initial
nursing assessment nutrition screening. Nutritional screening of patients in hospitals
within 24 hours is a national standard of The Joint Commission (TJC; Somanchi et al.,
2011). I sought to overcome this bias by adjusting for nutritional risk, as well as other
factors affecting supplement use--age, sex, BMI, diagnosis of malnutrition, and
cormorbidity score--through linear regression analysis.
I was a PRN (pro re nata, or “as needed”) registered dietitian at the hospital
during the initial planning stages of the study proposal, which provided better knowledge
of what factors may influence nutritional interventions, what type of data are collected in
the EMS, and how the study could be designed to provide the data of interest. I am no
longer employed by the hospital and thus believe I am free of bias in evaluating the
results.
Significance
It is expected that this study will contribute to the body of evidence on the use of
ONS in relation to patient and hospital outcomes, specifically for the diagnosis of HF. It
provides another perspective on whether this approach to nutritional care contributes to
potential benefits for patients and hospitals, and whether routine use of supplements may
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be beneficial for the regional medical center under study and other similar acute care
facilities. In practice, it may help provide guidance to hospitals, physicians, other
providers, dietitians, and nurses in the use of ONS. This type of information can help
hospital administrators and payers know whether more routine use of ONS is worth
supporting.
This study is expected to promote positive social change by examining aspects of
patient care in hospitals that can improve patient health and quality of life, and also
promote more efficient ways to use patient, hospital, and community resources. Use of
ONS and other nutrition interventions, such as consulting staff dietitians to determine
individualized plans of care, have the potential to improve the healing process, prevent
complications, and reduce the time patients spend in the hospital. This can mean
improved quality of life for patients and those close to them. It can also save valuable
resources for use in other needed areas, providing positive social benefit to the
community or general population, as well as individuals receiving hospital care.
Summary
This chapter has outlined the problem of malnutrition and the importance of
nutrition intervention for preventing and treating malnutrition. The role of nutrition
intervention in improving outcomes for hospitalized patients was reviewed. Research has
been reviewed on the effectiveness of nutritional supplements for older patients in
hospital and community settings, for orthopedic patients in the hospital, for postoperative
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patients, and those with pressure sores. Improved outcomes included reduced health care
costs in the community and the hospital (Arnaud-Battandier et al., 2004; Lawson et al.,
2003), smaller drops in albumin levels and better recovery among hip fracture patients
(Botella-Carretero et al., 2008), fewer complications and less weight loss in orthopedic
patients (Lawson et al., 2003; Miller et al., 2006), lower risk of pressure ulcer
development (Bourdel-Marchasson et al., 2000), and shorter LOS, improved nutritional
status, lower mortality risk, and reduced hospital readmission rates among acutely ill
older patients (Gariballa et al., 2007). Decreases in functional limitations were also
demonstrated in malnourished elderly patients (Neelemaat et al., 2012) .
The need for further study in other populations such as the general population,
other diagnoses, and the potential for routine supplementation was presented. The
research questions and hypotheses for this study were then provided. This study focused
on ONS use to improve outcomes for patients with a diagnosis of HF, a common
diagnosis with high rates of complications, high hospitalization costs, and high 30-day
readmission rates (Aziz et al., 2011; Kociol et al., 2013). The theoretical foundation of
the epidemiological triad was described, and the conceptual foundation was outlined to
describe the problem of malnutrition in hospitalized patients.
A literature review that presents further detail on the research described above
will follow in Chapter 2. In addition, further research background on the theoretical
foundation and conceptual framework will be presented.
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Chapter 2: Literature Review
Introduction
Malnutrition in acute hospital patients has been estimated to affect from 30-55%
of hospital patients worldwide (Agarwal et al., 2012; Barker et al., 2011; Somanchi et al.,
2011), with some studies finding malnutrition rates of up to 69% in hospitals (Singh et
al., 2006; Young et al., 2013). Research has demonstrated that the prevention and
treatment of malnutrition in hospital patients reduces cost of care, LOS, readmission
rates, mortality, and complication rates among patients (Correia & Waitzberg, 2003;
Somanchi, et al., 2011; Rasheed & Woods, 2013, Tappenden et al., 2013).
Malnutrition is costly not only to those who suffer from it, but to the health care
system as a whole. Correia and Waitzberg (2003) found that the overall costs for
hospitalized malnourished patients were 308.9% higher than for well-nourished patients
from 25 Brazilian hospitals. Significantly greater LOS, readmission rates, and mortality
rates have also been demonstrated among hospitalized patients who are malnourished
compared to those who are well-nourished (Aziz et al., 2011; Lim et al., 2012).
Factors contributing to malnutrition in the hospital include changes in
metabolism, altered nutrient absorption, anorexia, inability to chew or swallow, dietary
restrictions related to illness or tests, increased nutritional needs caused by disease or
infections; and inadequate food and beverage intake because of dislike of hospital foods
or special diets. Inadequate food and beverage intake to meet nutritional needs during
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hospitalization is one major cause of malnutrition, and research has shown that
inadequate intake is common among acute care patients (Agarwal et al., 2012; Hiesmayr
et al., 2009).
ONS that contain significant amounts of kilocalories (kcal), protein, and multiple
nutrients, are often provided as a convenient intervention to address the problem of
inadequate intake and help to prevent and treat malnutrition in hospitals. The
effectiveness of this approach has been demonstrated in a variety of research settings. A
multicenter trial in France found a reduced risk of pressure ulcer development among
elderly hospitalized patients who received two high-protein, high-calorie supplements
daily (Bourdel-Marchasson et al., 2000). Arnaud-Battandier et al. (2003) found that ONS
improved the nutritional status of elderly patients in a community setting, leading to
reduced health care costs. Miller et al. (2006) demonstrated that ONS were beneficial in
preventing the weight loss that commonly occurs among older adults at nutritional risk
following lower limb fractures. A meta-analysis by Stratton and Elia (2007) also showed
consistent clinical benefits—such as improved nutritional status and reductions in
complications—associated with the use of ONS in hospital and community settings. A
review of 55 studies by Milne, Avenell, and Potter (2006) concluded that the provision of
ONS in elderly hospital patients appeared to benefit individuals who were
undernourished at baseline. Patients using the supplements had fewer complications and
lower mortality rates compared to controls.

28

The remainder of this chapter will provide a detailed review of major literature
related to nutrition issues in hospitals, especially malnutrition, and the role of ONS and
other clinical nutrition interventions to help improve nutritional status of hospitalized
patients and improve hospital outcomes. I will start by summarizing the literature search
strategy I used, followed by a theoretical foundation for my study. This will include a
review of how malnutrition is defined, the tools used to identify it, and interventions that
have proven effective to help prevent or reduce the incidence of malnutrition in the
hospital setting. I will focus the review on studies related to the major variables in my
study.
Significant articles reviewed are summarized in the literature matrix in Table 1.
Next, I discuss the rationale for selection of the key variables in this study, previous
research related to these variables, limitations of previous research, and where there
remain gaps in the literature. I will then review and summarize studies related to my
particular research questions.
Literature Search Strategy
The main databases I used for my literature search were CINAHL, MEDLINE,
Cochrane Database of Systematic Reviews, and the ProQuest Dissertations Database. I
searched for articles using the Walden University Library, Google Scholar, the Google
Scholar link to the Walden Library via SFX by ExLibris, and related articles suggested
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by Science Direct and Google Scholar. I also accessed relevant articles referenced in
other journal articles, and the "cited by" feature of Google Scholar and Pub Med. The
following search terms were used in reviewing the literature: oral nutrition supplement,
nutrition supplements, LOS, nutrition, malnutrition, supplement, and hospital outcomes. I
focused on articles published in the past 5 years, but also reviewed seminal research
articles for earlier years.
Theoretical Foundation: The Epidemiological Triad
The theoretical framework for this paper is the epidemiological triad of person,
place and time. This triad is a key concept in descriptive epidemiology (Johns Hopkins
Bloomberg SPH, 2008). I applied the epidemiological triad in this study as I examined
patterns of health-related outcomes not only in relation to clinical factors, but according
to person, place, and time factors.
Schneider (2006) described how the epidemiological triad model was used by
John Snow, considered the "father of modern epidemiology," who investigated a cholera
outbreak in London in 1853-54 (time) by evaluating the geographic distribution of the
outbreak (place), and found that only those people using a particular water pump (place)
developed cholera, regardless of sex, age, "rank or occupation," or income status
(person). Snow removed the handle of the suspected pump, and the outbreak stopped.
Upon investigating the source of the water supplying the pumps, it was learned that the
water company supplying individuals who did not develop cholera had changed its water
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source between 1849 and1854 (time), from a part of the Thames River receiving heavy
contamination from the city's sewer systems to an area of the river without the
contamination (Schneider, 2006). The other water company continued to use the
polluted water as the water source for its customers. The use of person, place, and time
has continued to serve as the basis for epidemiological investigations in subsequent
years.
Applications of this Model in Ways Similar to this Study
Agarwal et al. (2012) used person, place, and time in a study of nutritional status
and oral dietary intake of 3122 participants in 56 hospitals in Australia and New Zealand.
Personal characteristics of participants included in the analysis included age, gender, and
ethnicity; they found that nutritional status of males and females was not significantly
different, but mean age was significantly different between well-nourished and poorlynourished patients. Timing involved a 24-hour data collection period, with comparison of
intake at different times of day (breakfast, lunch, and dinner meals); heaviest intake was
at the morning meal. Place involved hospital ward, with the largest percentage of
malnourished patients on the oncology wards (48%), followed by gastroenterology wards
(44%). The wards with the lowest percentages of malnourished patients were the
neurology wards (22%) and cardiology/respiratory wards (24%). A follow-up part of this
study (Agarwal et al., 2013) looked at outcomes data after 90 days (time) to show
hospital LOS, readmissions, and in-hospital mortality in this time period. However, these
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studies did not concern supplement use. No studies using the epidemiological triad could
be found involving nutrition interventions or supplement use and clinical or hospital
outcomes.
Rationale for Choice of this Theory
This study is an epidemiological study rather than a clinical trial. The study is a
retrospective, non-randomized observational study. My covariates cover the three aspects
of the epidemiological triad: person, place, and time. To investigate personal
characteristics related to use of ONS, I evaluated age, gender, ethnicity, height, weight,
and BMI in relation to supplement use and patient and hospital outcomes. For the place
variables, I chose to perform the study in a hospital setting, and compared supplement use
in relation to outcomes in various units at the hospital--an aspect that has been shown
previously to have a possible effect on my chosen outcomes (Agarwald et al., 2012).
Time aspects of my study included an evaluation of the time of year (by quarters) in
which patients were admitted, time patterns of supplement provision—such as whether it
was started on admission or later during the hospital stay--and whether the impact of
supplement use on patient and hospital outcomes was affected by such timing factors.
Conceptual Framework
Malnutrition leads to increased inflammation in the body which reduces the
ability of tissues to heal or to fight infection. Malnutrition impedes healing and recovery
of hospitalized patients, and treatment of or prevention of malnutrition has been shown to
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improve outcomes for hospitals, as well as for individual in medical facilities or at home
(Agarwal, 2013; Arnaud-Battandier et al., 2004). As mentioned earlier, malnutrition has
been estimated to affect from 30-55% of hospital patients worldwide (Agarwal et al.,
2012; Barker et al., 2011; Somanchi et al., 2011).
One cause of malnutrition is poor intake of food and beverages. Poor food intake
(less than 50% of food offered) is common in hospitals, among well-nourished patients as
well as malnourished patients; one study of 3122 patients in 56 hospitals in Australia and
New Zealand found poor intake in 55% of malnourished participants, and 35% of wellnourished participants (Agarwal et al., 2012). Thirty-two percent of the participants
overall in that study were found to be malnourished, using the Subjective Global
Assessment (SGA) tool.
A common reason for poor intake is "not hungry" (Agarwal et al., 2012, abstract).
However, patients may be able to consume a liquid nutritional supplement even when
their appetites are poor. ONS supplements have been shown to improve nutritional intake
Bourdel-Marchasson et al. (2000) found improved calorie and protein intakes and lower
rates of pressure ulcers in an intervention group receiving two nutritional supplement
beverages daily for 15 days.
For this reason, one traditional approach to prevent and/or treat malnutrition has
been through the use of high-calorie, high-protein nutrition supplements. I tested whether
the use of these supplements in hospitals might have a sufficient effect to reduce LOS.
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Literature Review Related to Key Variables and Concepts
A key concept in this study is malnutrition, and its relationship to patient and
hospital outcomes. Key variables in this study include the following: albumin levels;
prealbumin levels; use of high protein, high-calorie dietary supplements; nutrition
intervention through registered dietitian consultations; in-hospital weight changes; bodymass index; patient location in hospital; time of year of admission; patient characteristics
(age, gender, and ethnicity); diagnosis; and LOS.
Review of Studies Related to Key Concept: Malnutrition
Malnutrition can be described as "the condition that develops when the body does
not get the right amount of the vitamins, minerals, and other nutrients it needs to maintain
healthy tissues and organ function" (Farlex, 2014). Malnutrition often has not been
recognized in hospitals (Tappenden et al., 2013) and has not been easy to clearly
recognize or define in the hospital setting (Jensen, Bistrian, Roubenoff, & Heimburger,
2009; White, Guenter, Jensen, Malone, & Schofield, 2012). However, recognizing the
value of identifying and treating patients at high-risk nutritionally (whether or not they
are officially diagnosed with malnutrition), the Joint Commission (2012) standards
require hospital patients to receive nutritional screening within 24 hours of admission.
Definitions of malnutrition. Malnutrition has been defined by several methods in
the studies reviewed. One common method is the Subjective Global Assessment (SGA)
(Detsky et al, 1987). Factors included in the SGA include recent weight loss (amount and

34

pattern); changes in oral intake; adverse gastrointestinal symptoms that may affect food
intake such as nausea, vomiting, or diarrhea; presence of disease, physical assessment of
muscle wasting or edema; and subjective rating by physical exam. This tool been used by
a number of studies reviewed for this paper, and is often the tool used as a gold standard
for comparison and validation of other less burdensome tools.
The ICD-10-AM code for malnutrition in Australia defines malnutrition as a BMI
less than 18.5 kg/m2 combined with SGA ratings of moderately malnourished or severely
malnourished (ICD-10-AM, as cited by Agarwal et al., 2013).
Another tool that is a very abbreviated form of screening for malnutrition is the
Malnutrition Screening Tool (MST), developed by Ferguson, Capra, Bauer, and Banks
(1999). It consists simply of the following two questions: “Have you been eating poorly
because of a decreased appetite?” and “Have you lost weight recently without trying?”
(Ferguson et al., 1999, p. 460). These two questions were validated by Ferguson et al.,
and showed high sensitivity and specificity compared to the Subjective Global
Assessment. It was used along with the SGA by Agarwal et al. (2012), Agarwal et al.
(2014), and others.
Not all studies used a pre-designed tool. In a study on the benefits of a nutrition
intervention among malnourished elderly patients in the Netherlands, Neelemaat et al.
(2012) used the following criteria to identify malnourished patients:


Body Mass Index (BMI in kg/m2) < 20 and/or
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5% unintentional weight loss in the previous month and/or



10% unintentional weight loss in the previous six months (p. 184).
Malnutrition and patient and hospital outcomes. A number of studies have

shown that malnutrition adversely affects individual health outcomes and hospital
outcomes (Correia & Waitzberg, 2003; Lim et al., 2012; Agarwal et al., 2013). Cost of
hospitalization and LOS were higher in inpatient medical units in a tertiary-care hospital
in the Midwest among patients at risk for malnutrition compared to patients not at risk.
(Chima et al., 1997). In a study of 3122 patients from 56 hospitals in Australia and New
Zealand, median LOS for malnourished participants was 15 days compared to 10 days in
well-nourished participants (p < .0001) (Agarwal et al., 2013). In the same study,
participants consuming less than 25% of food offered also had significantly greater LOS,
with median LOS of 13 days compared to 11 days for those consuming at least 50% (p <
.0001). Correia and Waitzberg (2003) found reduced LOS (OR 0.7, CI [0.59, 0.83]),
increased complications (OR 1.60, CI [1.09, 2.35]), increased hospital mortality, and
higher overall hospital costs (by 309%) among 709 hospitalized patients over 18 years of
age, chosen randomly from 25 Brazilian hospitals. Agarwal et al. (2013) also found a
significant association between malnutrition and age 65 or greater, and emergency
admission to a hospital.
Nutrition interventions and malnutrition. Several studies have indicated that
the use of ONS and other nutrition interventions among hospitalized patients appear to
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have a greater effect among sicker or more malnourished patients in comparison to wellnourished or healthier patients. Philipson et al. (2013), in a 10-year retrospective study on
ONS use and hospital outcomes in patients in the Premier Perspectives Database, looked
at hospital outcomes in relation to ONS use. In this large database, they found 724,027
episodes of ONS use in the database of 44.0 million inpatient episodes. They used
propensity score matching to produce a comparison group of 1,160,088 non-ONS
episodes. Analysis of the data showed that, overall, those using the ONS were older,
sicker, and more likely to have had another recent hospital admission. But when the ONS
group was compared to a group of matched patients, LOS was reduced 21%, or 2.3 days
(95% CI [-2.4, -2.2]). In a prospective nutrition intervention study of 400 patients in two
medical wards at Johns Hopkins Hospital, Somanchi et al. (2011) identified malnutrition
in 53% of the study population. Those patients who received the nutrition intervention
received a clinical nutrition screening, dietary department consultation, and assessment.
LOS was reduced by an average of 1.93 days (CI [-3.19, 0.661]) in the nutrition
intervention cohort, and 3.2 days (95% CI [-6.43, 0.028]) in a those found to be severely
malnourished.
Review of Studies Related to Key Variables
Albumin level. Several studies reviewed for this paper used albumin levels as an
indicator for nutritional status, although there is some disagreement regarding the validity
of these lab values as indicators of nutritional status because of their high association
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with the inflammatory process—a common issue among hospitalized patients
(Tappenden et al., 2013). Low serum albumin is an established risk factor for pressure
ulcer development, as demonstrated in previous research, and used by BourdelMarchasson et al. (2000), in a prospective multi-center study evaluating the relationship
between provision of nutritional supplements, oral intake, and pressure ulcer
development among critically ill elderly hospital patients. They found that decreased
serum albumin was an independent risk factor for the development of pressure ulcers,
with an increase in risk by 1.05 for each 1 g/L decrease in serum albumin (95% CI [1.02,
1.07], p <.001). In a randomized, controlled clinical trial, Botella-Carretero et al. (2010)
administered two supplements daily for an average of 5.8 days to pre-hip fracture
patients, and found greater decreases in serum albumin and prealbumin levels in the
control group compared to the intervention group, as well as poorer recovery
postoperative in this group compared with the intervention group.
Weight changes. Lawson et al. (2003) measured weight changes, but reported
results in BMI changes. They found no significant change in BMI values over a 7-day
period. Potter, Langhorne, & Roberts (1996) reviewed 32 randomized controlled trials of
patients receiving oral or enteral protein-energy supplementation. Of these, 20 involved
oral supplementation. They found a 3.11% (CI [2.03, 4.20]) benefit in weight from
supplementation, using an alternative random effects model to account for differences in
whether supplemented patients showed greater weight gains, or smaller weight losses
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compared to controls. Milne et al. (2006), in a review of 14 trials, found a pooled
weighted mean weight change of 1.75% [1.12, 2.30]. However, Neelemaat et al. (2012)
did not find significant weight changes over a 3-month period among malnourished
hospitalized elderly patients who received ONS. Potter, Roberts, McColl, and Reilly
(2001), in a study of ONS in hospitalized elderly patients, found the difference in weight
change between the treatment group and control group was 2.8% weight improvement:
An increase of 2.0% (SD 4.5; n = 113) in the treatment group, compared to - 0.8% (SD
5.3; n= 121) in the control group.
High- protein, high-calorie dietary supplement use. In this study, ONS refers
to supplements containing at least 15% of kcal as protein, at least 200 kcal per serving,
and at least 20% of daily requirements for vitamins and minerals. Most of the ONS used
in the studies referenced contained at least 20% of kcal as protein. The importance of
protein for maintaining nutritional status, preventing malnutrition, and promoting healing
has been clearly established in the nutrition literature, as well as national and
international references (National Institutes of Health, 2014).
ONS have been shown to be related to improved patient outcomes in several
studies. In a randomized, controlled study of 445 hospitalized elderly patients, Gariballa
et al. (2006) found improvements in nutritional status indicators and a significant
reduction in non-elective hospital readmission rates among participants receiving ONS
compared to those receiving placebo drinks. Albumin levels were significantly higher at
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six-month follow-up among those receiving supplements, compared to those in the
placebo group, with values of 42.0 and 40.5, respectively (P = .04). This trial was limited
to people 65 to 92 years of age. Supplements were provided for six weeks, along with
"the standard hospital diet", indicating that participants consumed supplements even after
hospital discharge, since mean hospital LOS was reported as 9.4 days in the supplement
group and 10.1 days for the placebo group. For comparison, the average hospital LOS
among approximately 33 member countries of the Organisation for Economic Cooperation and Development [OECD] was 8.2 days in 2000, 7.2 days in 2009, and 7.0
days in 2011 (OECD, n.d). Mortality at six months was 14% for the supplement group,
and 9% for the placebo group. Adherence to supplements varied; graphs of percentage
consumed showed only about 14% of patients taking 75-100% of the supplement, 22% of
patients consuming 50-75%, 6% consuming 25-50%, and 58% of patients taking 0-25%
of supplements offered. Since the supplements contained 995 kilocalories (kcal) daily,
even 50% intake provided a substantial increase in daily kcal consumption for patients
(Gariballa et al., 2006, Figure 2).
Philipson et al. (2013), in a study of 724,027 episodes of ONS use out of
44,000,000 hospitalization episodes, found that use of ONS use was related to decreased
LOS, decreased 30-day readmission rates, and reduced episode cost, compared to the
matched comparison group. The variable ONS use is based on "the fraction of episodes
involving any ONS use in a given hospital in a given quarter" (p. 122), so the quantity of
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actual supplement consumed was not available. Because the data involved data from 460
sites, there would have been a variety of methods of supplement provision: In some
cases, supplement may be administered by nursing staff; at other sites the supplement
may have been available only at med pass. At some sites, supplement may be sent on
patient trays, while it may be offered between meals at other hospitals. Additionally, at
some hospitals supplements may be sent automatically, whether patients want it or not;
while other hospitals may not send supplements unless the staff has determined that the
patient has some interest in drinking it. Further information on rates of supplement
consumption or compliance is under the section Consumption of ONS Offered below.
While the database included billing information, which was useful in determining
supplement use, it was limited in that it did not contain health information for patient
hospitalization episodes analyzed.
In a study of ONS use among long-term care residents, Heyman, Van De
Louverbosch, Meijer, and Schols (2008) found significant healing of pressure ulcers
among elderly residents receiving the supplements. Average intake was 2.3 + 0.56
servings of a 200 ml supplement providing a total daily average of 575 kcal, and 46 g
protein, as well as other supplemental nutrients demonstrated in previous studies to help
promote healing (these included arginine, vitamin C, vitamin E, and zinc). Measurements
after three weeks of supplementation revealed an average decrease in pressure ulcer area
from 1580 + 3743 mm2 to 1103 + 2999 mm2 (p < .0001) after three weeks; after nine
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weeks, average size was 743 + 1809 mm2 (p < .0001). Exudate levels were also reported
to have decreased significantly during the supplementation period. While there were
significant improvements in the pressure ulcers over the 9-week supplementation period
of this study, there were no comparison groups or placebo groups with which to compare
results. This was done to provide a larger sample size, as well as because of ethical
concerns of providing placebos to this malnourished population (Heyman et al., 2008).
Therefore, one cannot know how much healing normally takes place without the use of
such supplements over this period of time, and how much of the improvement can be
attributed to the use of the supplements. Additionally, there was potential bias in this
study because it was supported by Nutricia Belgium, the company that produces the
supplement.
I did not find any studies specifically on the use of ONS among hospitalized HF
patients. However, Rozentryt et al. (2010) performed a small pilot study (n=29) of ONS
in an outpatient clinic for patients with heart failure in Poland. In this prospective,
randomized, placebo-controlled study, Rozentyrt et al. found significant improvement in
quality of life and weight gain over the 18 weeks of the study, with an average weight
gain of 3.6±4.7% (p = .007) among the 19 patients who completed the treatment arm of
the study.
Nutrition intervention through dietary department or registered dietitian
consultations. In a prospective cohort intervention study of 400 patients in two medical
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wards at Johns Hopkins Hospital, LOS was 1.93 days lower (CI [-3.19, 0.661]) among
patients who received s nutrition intervention compared those without the intervention
(Somanchi et al., 2011). The intervention consisted of a nutrition assessment form filled
out by a nurse, followed by consultation of the clinical nutrition department and
monitoring of the consultation. Among a subset of patients with severe malnutrition in
this same study, LOS was reduced by an average of 3.2 days (95% CI [-6.43, 0.028]).
Somanchi et al. (2011), in a prospective intervention cohort study of 400 patients in two
medical wards at Johns Hopkins Hospital, identified malnutrition in 53% of the study
population. Those patients who received the nutrition intervention received a clinical
nutrition screening, dietary department consultation, and assessment. LOS was reduced
by an average of 1.93 days in nutrition intervention cohort, and 3.2 days in the severely
malnourished group. Neelemaat et al. (2012) also evaluated the effect of an intervention
that included telephone counseling by a dietitian after hospital discharge, in addition to an
enhanced diet, ONS, and supplementation of vitamin D3 and calcium. As with the
previously mentioned study, the effects of dietary intervention via dietitian were not
separated from use of supplementary nutrition products alone.
Hospital length of stay (LOS). Correia and Waitzberg (2003) looked at LOS,
mortality, morbidity, and costs in a retrospective cohort study that included 709 patients
from 25 hospitals in Brazil. All participants were over 18 years of age. They used the
SGA tool to classify patients as well-nourished or malnourished, and found an average
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difference in LOS for well-nourished patients and malnourished patients to be 10.1 +
11.7 days. Milne et al (2006) found no significant difference in LOS in patients who were
supplemented, but noted that patients who were undernourished and received
supplements did have a shorter LOS of 3.30 fewer days compared to 0.84 fewer days for
patients not undernourished.
Joshi, D’Souza, and Madhavanevision (2004) examined factors related to
differences in LOS in congestive heart failure patients from the National Inpatient
Sample, part of a project sponsored by the Agency for Healthcare Research and Quality.
Significant differences were found by race, age, gender, and primary payer as
Private/HMO (other payers considered were Medicare, Medicaid, and self-pay).
Therefore, these factors have been included as covariates in my study.
High or low BMI. BMI, defined as 10,000 times weight in kg divided by height
in meters2, is used as a measure of nutritional status, with different values associated with
various levels of weight status. According to the Centers for Disease Control and
Prevention, a BMI of less than 18.5 is considered below normal in the United States
(CDC, 2014) and is associated with poor nutritional status. Agarwal et al. (2013) used
this same value of BMI as one criteria for malnutrition, based on the Australian version
of ICD-10 coding that includes this as a definition of malnutrition (as cited by Agarwal et
al., 2013). Lawson et al. (2003) also used BMI values as part of their determination of
nutritional status of participants receiving post-operative ONS in the UK, but did not
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classify patients as well-nourished or malnourished based on BMI values. Neelemaat et
al. (2012) used BMI < 20 as an indicator of malnutrition in their study of the effects of
nutritional support on functional limitations of malnourished hospital patients over aged
60 or older in the Netherlands. It can be seen that BMI values varied somewhat according
to study, which may be related to different criteria for malnutrition according to country
of origin of the study.
Because of the relationship of BMI to nutritional status, it will be used as a
covariate in my study.
Patient demographics. The rate of malnutrition is generally higher among
patients 65 years of age and above. Agarwal et al. (2013) found a significant association
between older age (65 years and over), and malnutrition among 3,122 hospitalized
patients. They did not find any significant difference in percentage of malnourished
patients between males and females. In regard to the relationship between ONS and
patient characteristics, very little information was available in the literature examined,
other than the finding that supplements were associated with greater improvements
among those who were malnourished compared to well-nourished patients. This
information suggests a gap in recent literature regarding ONS effectiveness and
demographic information that my study will address. It also shows a relationship between
malnutrition and age which will need to be adjusted for in my study to prevent
confounding.
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In regard to demographic factors affecting the outcome of LOS, Joshi et al. (2004)
found significant differences in LOS among HF patients according to race, age, gender,
and payer in their examination of factors affecting LOS among HF patients in the
National Inpatient Sample.
Timing of nutrition intervention or supplement use. Studies involving timing
of supplement use as a variable were not available, although one group of authors
(Botella-Carretero et al., 2010) addressed the potential for differences in outcomes
depending on timing of supplementation by comparing results of perioperative
administration of ONS to hip fracture patients to results of an earlier study they
performed on post-operative provision of ONS (Botella-Carretero et al, 2008). Both
studies examined the same outcomes, and found beneficial results from supplementation
in both cases. The dearth of information in this area, especially in regard to season of the
year, indicate a gap and suggest that further studies may be appropriate.
Patient Location in Hospital and Season of Year. No study was available that
considered differences in nutrition interventions or ONS provision according to patient
location or season of the year. Park, Andrade, Mastey, Sun, and Hicks (2014), in an
examination of facility-related factors in relation to 30-day hospital readmissions for
congestive heart failure, pneumonia, and chronic obstructive pulmonary disease at a
community hospital in Massachusetts, found some variation by patient location in
hospital in relation to readmission rates. They found fewer readmissions for patients
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discharged from the cardiac floor vs. medical/oncology floors (OR= 0.85, p = .08), and
that readmissions were significantly more likely in winter than summer (OR = 1.54; p =
.0008). These results indicate a need for further study in this area.
Consumption of ONS offered. One issue noted in this literature search was the
question of whether those who receive nutritional supplements are actually consuming
them. There have been studies questioning whether supplements provided are actually
consumed (Gosney, 2003). A multi-center study by Bourdel-Marchasson et al. (2000),
evaluating the relationship between provision of nutritional supplements, oral intake, and
pressure ulcer development among critically ill elderly hospital patients, found an intake
of 60% of the two high-protein, high-calorie supplements provided daily in week one,
with an increase to 99% the second week. Additionally, a recent review of 46 studies,
covering 2282 persons on ONS, found a 78% overall rate of supplement consumption in
all settings, and 67% in hospital settings (Hubbard, Elia, Holdoway, & Stratton, 2012).
Botella-Carretero et al. (2010) found an average intake of 52.2 + 12.1% of the two daily
supplements provided in their study of geriatric hip fracture surgery patients. Gariballa et
al. (2006) found an average of 23-48% consumption of supplements over a six-week
period including hospitalization and post-hospitalization. Houwing (2003) found an
intake of at least 75% of the supplements among approximately 75% of participants.
Miller et al. (2006) found that the median consumption of ONS by patients following
lower limb fractures over a 42-day period was 67%. These patients would not have been
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acutely ill during this entire time frame; some performed resistance training during the
course of the study.
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Table 1
Summary of the Literature on Nutrition Interventions, ONS Use, Malnutrition, and Clinical and Hospital Outcomes
Author &
Year

Title

Study Design

Study Population

Independent
Variables

Dependent
variables

Results

Other

Agarwal, E.,
Ferguson, M.,
Banks, M.,
Batterham, M.,
Bauer, J.,
Capra, S.,
Isenring, E.
(2013)

Malnutrition and
poor food intake
are associated with
prolonged hospital
stay, frequent
readmissions, and
greater in-hospital
mortality: results
from the Nutrition
Care Day Survey
2010

Prospective
cohort study

3122 patients
recruited from 56
hospitals in
Australia and
New Zealand

Nutritional
status:
malnourished,
severely
malnourished, or
well-nourished;
meal intake

LOS,
readmission
rates, inhospital
mortality

LOS greater in malnourished patients
(15 days vs. 10 days in well-nourished
patients); p < .0001), regardless of
disease status. Median LOS
significantly greater in patients with
meal intake of < 25% (13 days)
compared to intake > 50% (11 days); p
< .0001.
Readmissions rates significantly higher
in malnourished patients (36%) vs.
well-nourished patients (30%); p <
.001.
OR for 90-day in-hospital mortality for
malnourished patients =1.91, CI [1.09,
3.34], p = .023.
OR for 90-day in-hospital death for
intake < 25%, = 1.99, CI [ 1.13, 3.51],
p = .017

Significant
association
between
malnutrition and
age > 65;
emergency
admissions;
non-surgical, nonmedical
admissions.
Nutritional status
was
based on the ICD10-AM2,13;
malnutrition was
defined as BMI
<18.5, and SGA
ratings of moderate
or severely
malnourished
(table continues)
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Author &
Year
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Study Design
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Dependent
variables

Results

Other

ArnaudBattandier, F.
Malvy, D.
Jeandel, C.
Schmitt, C.
Aussage, P.
Beaufrère, B.
Cynober, L .
(2004)

Use of oral
supplements in
malnourished
elderly patients
living in the
community: a
pharmacoeconomic study

Prospective
longitudinal
cohort study,
12 months
follow-up.
Group 1physicians
frequently
prescribe
ONS, Group 2
rarely

378 patients of
90 general
practitioners in
France. All
participants were
over 70 years of
age,
malnourished,
and living at
home or in
institutions.

Frequent or rare
use of ONS

1. Nutritional
status using
MNA (MiniNutritional
Assessment)
2. Cost of
medical and
hospital care

MNA improved significantly more in
group 2 (p < 0:01). (Repeated
measures over time, regression with
propensity score method; Student's ttest).
Net cost savings including cost of
supplements: EUR -195 ; 90% CI
[929, 478]

Measured
malnutrition using
MNA tool

BotellaCarretero et
al. (2010)

Perioperative oral
nutritional
supplements in
normally or mildly
undernourished
geriatric patients
submitted to
surgery for hip
fracture: a
randomized
clinical trial

Randomized,
controlled
clinical trial

60 participants
(30 in
intervention
group, 30
control), from
one hospital in
Spain; post-hip
fracture patients
over 65 years old
requiring
surgery, admitted
5/07 to 9/08,
excluding
patients with
severe/
moderate
malnutritiona

Perioperative
ONS, vs. no
ONS

A. For intervention group vs. control
(using repeated measures GLM):
1. Less decrease in albumin in
intervention group. F = 22.536, p <
.001 (within subjects factor).
2. Improved post-op recovery
(F = 5.763, p < .002).
3. Smaller decrease in prealbumin . F
= 6.654, p < .001 (within-subjects
factor).
4. No significant difference for change
in BMI: F = 2.509, p < .089 (withinsubjects factor)
5. Fewer post-op complications; not
significant.
B. Rate of post-op complications
associated with lower intake of
protein; No significant difference in
(table continues)
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Author &
Year

Title

Study Design

Study Population

Independent
Variables

Bourdel
-Marchasson,
I., Barateau,
M., Rondeau,
V., DequaeMerchadou,
L., SallesMontaudon,
N., Emeriau,
J., & ...
Dartigues, J.
(2000).

A multi-center
trial of the effects
of oral nutritional
supplementa-tion
in critically ill
older inpatients.
GAGE Group.
Groupe Aquitain
Geriatrique
d'Evaluation

Propsective
multicenter
trial over 19
hospital
wards. N =
672 (total) ;
295 in the
nutritional
intervention
group; 377 in
the control
group

672 critically ill
hospitalized
patients > 65
years old, from
19 hospital wards
in SW France;
295 participants
in intervention
group; 377 in the
control group.
Patients in
control group
comparable by
age, C-reactive
protein, and sex
distribution

Provision of two
high protein
ONS daily, vs no
supplements.

Chima, C. S,
Barco, K.,
Marci L. A.
Dewitt, M. L.
A., Maeda,
M.,Teran, J.
C.,Mullen, K.
D. (1997)

Relationship of
Nutritional Status
to Length of Stay,
Hospital Costs,
and Discharge
Status of Patients
Hospitalized in the
Medicine Service

Prospective
cohort

Patients in 3
medicine units in
tertiary-care
hospital in
Midwestern U.S.,
admitted
throughout
December 1994

At-risk or not-atrisk for
malnutrition

Dependent
variables

Results

Other

ONS
tolerance, time
from surgery
to
mobilization.
Protein &
energy intake,
incidence of
pressure
ulcers

changes for BMI, tricipital fold, or
mid-brachial circumference, or LOS

Protein & energy intake higher in
intervention group all days measured;
p <.001 for all 5 days for protein, 3 of
the 5 days measured for energy
(Student's t-test).
Relative risk of pressure ulcer
development at 15-day follow-up for
control group =1.57; 95% CI [1.03,
2.38] ; (p = .04) using multivariate
Cox proportional model

.

LOS, costs
and
reimbursement, and
discharge
placement

Median LOS 4 days for not-at-risk
group, 6 days for at-risk group (p <
.001).
Mean cost: $4,563 for not-at-risk
patients, $6,196 for at-risk (p < .02).
Readmission rates not significantly
different.
Highest rates of malnutrition in
patients with liver disease

Malnutrition
defined by any of
the following:
weight for height
<75% IBW4,
albumin level <30
g/L on admission,
or weight loss of
≥10% in month
prior to admission

(table continues)
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Dependent
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Correia, M. I..
T. D.,
Waitzberg, D
L. (2003)

The impact of
malnutrition on
morbidity,
mortality, length
of
hospital stay and
costs evaluated
through a
multivariate
model analysis

Retrospective
cohort study

709 patients,
aged 18 or over,
chosen randomly
from 25
Brazilian
hospitals

Nutritional
status: Wellnourished or
malnourished

LOS,
complications,
mortality,
hospital costs

Cox multivariate model for IV and
LOS: OR 0.7, CI [0.59, 0.83]; multiple
regression for complications on
malnutrition: OR 1.60, CI [1.09, 2.35];
univariate analysis with chi-square test
to determine RR between IV and
morbidity, LOS, and mortality.
Overall costs for hospitalized
malnourished patients 308.9% higher
than well-nourished patients.

Malnutrition
determined by
Subjective Global
Assessment

Gariballa,
Forster,
Walters, &
Powers
(2006)

A randomized,
double-blind,
placebo-controlled
trial of nutritional
supplementation
during acute
illness

Randomized,
double-blind,
controlled
study

445 hospitalized
patients aged 65
to 92 years, in
the UK

Receipt of highcalorie ONS vs.
placebo

1. Hospital
readmission

1. Adjusted hazard ratio for
readmission: 0.68%, CI [0.49-0.94].
2. LOS: supplement group = 9.4 days,
placebo group = 10.1 days.
3. Mortality at six months: 14% for
the supplement group, 9% for the
placebo group.
4. Serum albumin at 6 months: 42.0
(supplement group), 40.5 (placebo
group), respectively (P = .04). No
change in BMI, body weight, MUAC,
or TSF, or serum transferrin.

2. Hospital
LOS
3. Mortality at
6 months
4. Nutritional
status

Hoekstra, J.
C.,
Goosen, J. H.
M.,
de Wolf, G.,
& Verheyen,
C. (2011)

Effectiveness of
multidisciplinary
nutritional care on
nutritional intake,
nutritional status
and quality of life
in patients with
hip fractures: a
controlled
prospective cohort
study

Controlled
prospective
cohort study

Hospital
inpatients with
operative
intervention
following hip
fracture, over age
65. Intervention
group = 61
patients; control
group = 66
patients.

Multidisciplinary
Nutrition
Intervention.
Dietitian consult
for high-risk
patients.

Protein &
energy intake;
quality of life
(EQ-5D index
scores &
VAS-scores);
Number
classified as
malnourished

Significant increase in protein &
energy intake in intervention group.
Significantly less reduction in EQ-5D
(p =.004) and VAS (p =.039) in
intervention group.
At 3-month follow-up, control group
had significant increase in patients
classified as malnourished or at
nutrition risk; intervention group had
significantly fewer than control (p
=.019).

Nutritional status
was determined by
the Mini
Nutritional
Assessment
(MNA),

(table continues)
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Dependent
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Houwing, R.
(2003).

A randomised,
double-blind
assessment of the
effect of
nutritional
supplementation
on the prevention
of pressure ulcers
in hip-fracture
patients

Double-blind,
randomised,
placebocontrolled trial

103 hip fracture
patients from 3
centers in the
Netherlands; 51
received
supplements, 52
received placebo.

400 ml daily of
ONS vs. placebo

Incidence of
stage I and II
pressure
ulcers (PUs);
time to
development
of PU;
duration of
ulcer;
maximum
wound size.

ONS group vs. placebo group:
Incidence of stage I PU: 31.4% vs.
36.7% (p = .674); stage II pressure
ulcers: 18%, vs. 28% (p = .345).
First day of PU: 3.6 +0.9 (ONS) vs.
1.6 + 0.9 (placebo), p = .090.
Size: 1.6 + 0.3 vs. 2.2 + 0.4 (p = .232)

Supplement
fortified with
protein, zinc,
arginine, and
antioxidants

Lawson, R.
M., Dishi, M.
K., Barton, J.
R., & Cobden,
I. (2003)

The effect of
unselected postoperative
nutritional
supplementation
on nutritional
status and clinical
outcome
of orthopaedic
patients

Prospective
controlled

181 patients in
two adult
orthopedic wards
in hospital in
UK. Study
group: n=84;
control group:
n=97.
Overall,
participants were
not malnourished
(p. 45)

Two ONS daily
starting after
surgery (study
group)

Number of
major &
minor
complications
Energy intake,
Protein intake,
nutritional
status,
albumin, CRP,
transferrin

Significantly more major
complications in control group; no
significant difference in minor
complications.
(p =0.2).
No significant difference in nutritional
status, albumin change, or CRP change
Transferrin and hgb changes: Week 1
reduction significantly greater in
control group (p =.002 for each).
Control group had higher hospital
costs and treatments.

Not malnourished
patients

Lim, S. L.,
Ong, K. C. B.,
Chan, Y. H.,
Loke, W. C.,
Ferguson, M.,
& Daniels, L.
(2012)

Malnutrition and
its impact on cost
of hospitalization,
length of stay,
readmission and 3year mortality

Prospective 3year cohort
study and a
matched case
control study

Newly admitted
hospital patients,
18-74 years old;
818 participants.

Nutritional
status:
Malnourished vs.
well-nourished

LOS;
readmission in
15 or 90 days
and 6 months;
inpatient
mortality, cost
of hospital
stay

Malnutrition found in 29% of patients.
These had greater LOS (6.9-7.3 days,
vs. 4.6-5.6 days (p< .001), and greater
change of readmission within 15 days
(RR 1.9, CI [1.1, 3.2]);
Malnutrition significant predictor of
mortality: Adjusted hazard
ratio = 4.4, 95% CI [3.3, 6.0], p < .001

Nutritional status
determined by
Subjective Global
Assessment

(table continues)
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Study Design
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Dependent
variables

Results

Neelemaat, F.,
Bosmans, J.
E., Thijs, A.,
Seidell, J. C.,
& van
Bokhorst-de
van der
Schueren,
(2012)

Oral nutritional
support in
malnourished
elderly decreases
functional
limitations with no
extra costs

Randomized
controlled trial

210
malnourished
hospitalized
patients aged 60
or over; 105 in
intervention
group; 105 in
control group,

Special diet,
ONS, calciumvitamin D
supplement,
telephonic
dietitian
counseling until
3 months postdischarge.

1. Quality
Adjusted Life
Years
2. Frequency
and duration
of physical
activities
3. Functional
Limitations

1. No significant difference in QALYs
2. No significant difference in physical
activities
3. Significantly greater decrease in
functional limitations in intervention
group: Mean difference = -0.72, 95%
CI [-1.15, -0.28]

Park, L.
Andrade, D.
Mastey, A.
Sun, J.
Hicks, L.
(2014)

Institution specific
risk factors for 30day readmission at
a community
hospital: a
retrospective
observational
study

Retrospective
Observational

101 patients (the
34 readmitted
patients above as
well as 67 nonreadmitted
patients)
discharged
between January
1, 2011 to April
31, 2011 with
CHF or PNA.

Hospitalist
census and hours
worked on the
discharge day;
hospital
associated factors
(i.e. floor of
discharge,
Season, day of
week of d/c)

30-day
hospital
readmission
for dx of CHF,
pneumonia
and COPD

Readmission rates by dx:
CHF = 19.6%
Pneumonia = 13.0%
Chronic obstructive pulmonary disease
= 14.7%
Readmissions significantly more likely
in winter than summer; OR = 1.54; p =
.0008.
Fewer readmissions for patients
discharged from the cardiac floor vs.
medical/oncology: OR= 0.85, p = .08).

Somanchi, M.
Tao, X., &
Mullin, G. E.
(2011)

The Facilitated
Early Enteral and
Dietary
Management
Effectiveness
Trial in
Hospitalized
Patients With
Malnutrition

Prospective;
Intervention,
cohort with
comparison
group

400 patients in
two medical
wards at Johns
Hopkins
Hospital.

Clinical nutrition
screening,
consultation,
Assessments.

Prevalence of
malnutrition;
LOS, Case
Mix Index,
DRG coding
of
malnutrition,
nutrition
intervention

Malnutrition found in 53% of study
population.
Reduced LOS of 1.93 days in nutrition
intervention cohort; reduction by 3.2
days in
severely malnourished group

Other

Malnutrition
screening tool
included:
Poor intake, wt
loss, BMI, %IBW,
albumin

Notes. ONS = Oral Nutrition Supplements; ICD-10-AM = International Classification of Disease and Related Health Problems, Tenth Revision, Australian Modification; IBW = Ideal body
weight.; CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease.
a
In this study, patients with severe/moderate malnutrition were "those with a weight loss of more than 5% in the previous month or more than 10% in the previous 6 months from their usual
weight, and/or serum albumin concentrations below 2.7 g/dL" (Botella-Carretero et al., 2010, p. 575).

54
Critique of Methods
Most of the studies found on malnutrition and the benefits of in-hospital nutrition
interventions involve only elderly patients (over 65years of age). Many involve only
malnourished patients. In the latter studies, definitions of malnutrition vary: Many
studies use the SGA tool, others use lab values, weight changes, or BMI. The SGA is a
long questionnaire and it would not be practical to administer it to every hospital patient
on a routine basis. Also, some measures of nutritional status--such as weight changes,
dietary intake, or lab values--may vary greatly during a given hospital stay, so defining a
"high-risk" or malnourished patient may be problematic at times; a patient may be
considered to be malnourished based on measurements from one day but well-nourished
on another, depending on measures used.
Measures of nutritional status may vary by country. For example, BMI is used as
one indicator of nutritional status, but the cutoff point for underweight or malnutrition
vary in studies from different countries. As mentioned earlier, a BMI of less than 18.5 is
considered below normal, or underweight, in the United States (CDC, 2014), and used in
medical coding to define malnutrition in Australia (Agarwal et al., 2013). Therefore,
Agarwal et al. used this value of BMI as one criteria for malnutrition in their study of
hospitalized patients in Australia and New Zealand. However, Neelemaat et al. (2012)
used BMI < 20 as an indicator of malnutrition in their study of the effects of nutritional
support on malnourished hospital patients in the Netherlands.
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Lawson et al. (2003) analyzed change in BMI rather than weight during seven
days of their hospital stays and found no significant change, despite previous evidence
showing that ONS were associated with weight gain. The use of BMI changes instead of
weight changes, while useful in showing if subjects moved into higher-risk BMI
categories, can introduce measurement errors, since it requires measurement of height
and weight. Except in unusual circumstances (bilateral amputations, or compression
fractures), a person's height remains constant over the course of a hospitalization. Height
is not easily measured in a bed-ridden person; therefore, an additional extra measurement
of height provides the opportunity for additional error in results.
Most of the studies available were focused on specific diagnoses, such as hip
fractures (Botella-Carretero et al., 2010; Hoekstra et al., 2011; Lawson et al., 2003) or
wound healing (Miller et al., 2006) ; one involved pressure ulcers in orthopedic patients
(Houwing, 2003). Additionally, several provided supplements in the hospital and
continued them post-discharge Neelemaat et al. (2012) offered supplements during
hospitalization and for 3 months after hospital discharge; Gariballa et al. (2006) provided
supplements for 6 weeks—at least 1 month longer than the average LOS in their study.
In a study showing reduced LOS associated with a nutrition intervention at Johns
Hopkins Hospital (Somanchi et al., 2011), the details of the nutrition intervention are not
described. The title and content of the paper suggest that an enteral nutrition intervention
(tube feeding) was involved, but no description of a type or dose of feeding product are
provided.
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Some studies that considered nutritional intake as an outcome only used a 24-hour
intake window. This was true in a study by Agarwal et al. (2013) of malnutrition in
Australia and New Zealand. Nutritional intake, one of the IVs in the study, was
determined for only one 24-hour period. Lawson et al., 2003) also only used a 24-hour
period to assess adequacy of nutritional intake; they looked at energy and protein intake
as one outcome in a study of post-operative ONS provision in orthopedic patients, using
data from a random 24-hour intake analysis among a subsample of participants. Intake for
only a 24-hour period may not be a reliable measure of a patient's intake during a hospital
stay, because it may be affected by so many factors, such as whether they were on special
dietary restrictions for that day, or whether they had nausea/vomiting for just that day,
had a recent procedure, or various other factors that could affect meal intake. Several
studies used subjective estimations of amount of meals eaten. While this can provide an
idea of amount eaten, it can also vary among those observing and recording meal intake,
and may not be a reliable estimate of kcal and protein consumed. For example, a person
may be considered to have eaten 50% of a meal, because they ate 100% of their rice and
vegetables; however, this may only provide about 124 kcal and 4-5 grams of protein.
Another patient may also be scored at 50% of meal eaten after consuming only their meat
and dessert, but this may amount to 500 kcal and 22 grams protein. Another may drink
several drinks and eat dessert, providing perhaps 500 kcal but only 1-3 grams protein, and
be scored at 25% consumed. In contrast to this, Miller et al. (2006) used 5-day plate
waste to determine patient intake levels.
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Supplements were also provided at different times during the hospitalization, or
for different periods of time in different studies, making the results hard to compare. For
example, Gariballa et al. (2006) gave supplements over a period of six weeks, but mean
hospital LOS among participants was 9.4 days for the intervention group, and 10.1 days
for the placebo group, indicating that supplements were provided after discharge in
addition to the hospital stay. However, LOS was one of the outcomes. Additionally,
during the hospital stay, the participants received standard hospital diets, but there was no
indication of what participants ate once they left the hospital. As discussed earlier,
Botella-Carretero et al. (2008) looked at ONS use after surgery among elderly hip
fracture patients compared to a control without supplement provision. The second study
by the same authors (Botella-Carretero et al., 2010) examined the same outcomes among
patients in whom the supplement was started prior to surgery.
The small study of ONS among outpatients with HF and cachexia by Rozentryt et
al. (2010) was too small for definitive conclusions; out of 29 patients starting the study,
only 24 patients remained in the study after the 18 weeks were completed, with only 5
receiving placebo drinks. The authors also appeared to compare initial data of all 29
patients with final data for only 24 patients.
Lacking in all the studies reviewed is the use of the epidemiological triad to
examine variables. There is little information on how various personal characteristics
(other than older age), patient location in the hospital, and timing of supplementation, are
related to outcomes. The only personal characteristic studied is ONS use in patients over
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65 years of age. In this care, there is good evidence that patients 65 years of age and older
are more likely to be malnourished, and ONS supplementation in malnourished patients
has been more likely to produce significantly positive outcomes.
Summary and Conclusions
As described above, malnutrition has been identified in 30-69% of hospital
patients worldwide. Malnutrition among hospitalized patients has been shown to
adversely affect individual health outcomes and has been associated with increased LOS;
increased rates of complications, mortality, readmissions; and increased hospitalization
costs.
There is evidence that ONS use in hospitals may be an effective and efficient way
to prevent or reduce the adverse consequences of malnutrition. Its use has been associated
with improved patient and hospital outcomes, reduced LOS, and reduced readmission
ratesNutrition intervention by clinical nutrition staff, which often includes the
administration of ONS or enteral nutrition support, was shown to be an effective way to
improve clinical outcomes in several studies (Hoekstra et al., 2011; Neelemaat et al.,
2012; Somanchi et al., 2011).
Previous prospective case-controlled studies have demonstrated improved patient
and hospital outcomes or reduced costs among selected patient populations, including
elderly patients in the community (Arnaud-Battandier et al., 2004), elderly hospitalized
patients (Gariballa et al., 2007), and hospitalized orthopedic patients. Clinical benefits
among orthopedic patients have included reduced weight loss (Miller et al., 2006),
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improved recovery and smaller drops in serum albumin (Botella-Carretero et al., 2010),
and fewer complications (Lawson et al, 2003); Neelemaat et al. (2012) showed fewer
functional limitations among patients receiving ONS. In a review of 55 studies, Milne et
al. (2006) found that the provision of ONS in elderly undernourished hospital patients
was associated with fewer complications and lower mortality rates compared to controls.
Benefits have also been shown among elderly hospitalized patients at risk for pressure
ulcer development (Bourdel-Marchasson et al., 2000), and elderly undernourished
hospital patients (Milne et al., 2006). Results of improved outcomes among patients
through nutrition interventions were especially salient in elderly patients, and appear to
be magnified among patients with poor nutritional status (Milne et al., 2006; Philipson et
al., 2013).
Nutrition intervention by clinical nutrition staff, which often includes the
administration of ONS or enteral nutrition support, has also been shown to be an effective
way to improve clinical outcomes (Hoekstra et al., 2011; Neelemaat et al., 2012;
Somanchi et al., 2011). Stratton and Elia (2007), in their meta-analysis on the use of ONS
in hospital and community settings, revealed consistent clinical benefits—such as
improved nutritional status and reductions in complications—associated with the use of
ONS.
Regarding HF patients, Aziz et al. (2011) found a significant association between
LOS and lower nutrition risk scores among HF patients, using a risk score derived from
albumin levels and weight changes, however ONS were not involved in this study. In a
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small prospective placebo-controlled study of 29 outpatient heart clinic patients,
Rozentryt et al (2010) found significant improvements in weight and quality of life
among HF patients receiving ONS; but there were only six patients in the placebo group,
which was not large enough to make definitive conclusions.
Gap Addressed by this Study
All of the studies described using clinical and individual hospital data were
prospective; some were randomized controlled studies. While these are of benefit in
established associations, they do not reflect what happens in typical day-to-day hospital
practice. Limited research was found regarding the use of ONS in usual hospital practice,
and no studies were identified that looked at epidemiological triad factors of person,
place, and time and how these variables relate to the benefit of nutritional intervention
and supplementation.
Most available evidence in recent years showing improved outcomes related to
ONS use is among selected populations. This includes elderly patients (ArnaudBattandier et al., 2004; Botella-Carretero et al., 2010; Bourdel-Marchasson et al., 2000;
Neelemaat et al., 2012), orthopedic patients (Lawson et al., 2003)—especially those with
hip fractures (Botella-Carretero et al., 2010; Hoekstra et al., 2011), and patients with
pressure ulcers (Houwing, 2003).
Evidence is limited, however, on the effectiveness of ONS for patients with a
primary diagnosis of heart failure. No studies specifically on ONS among hospitalized
HF patients could be found, and the study on outpatients with CHF by Rozentryt et al.
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(2010), had too small of a sample size for definitive conclusions. Therefore, a gap exists
for the study of ONS among hospitalized HF patients in general. Additionally, no studies
were found that considered the epidemiological triad in choice of covariates. Therefore,
my study is intended to help fill a gap on studies of the relationship of ONS use to
clinical and hospital outcomes among HF patients, with the added consideration of the
epidemiological triad in the analysis of covariates.
Additionally, most of the current research appears to be from outside the United
States. Several studies (Agarwal et al., 2012; Agarwal et al., 2013; Miller et al., 2006)
took place in Australia and New Zealand; two in France (Arnaud-Battandier, et al., 2004;
Bourdel-Marchasson et al, 2000); others in Spain (Botella-Carretero et al., 2010); the UK
(Lawson et al., 2003); and the Netherlands (Hoekstra et al., 2011; Neelemat et al, 2012);
one was in the Baltimore, Maryland (Somanchi et al., 2011). The latter appeared to
involve only enteral nutrition support, and not oral supplements. None of the studies
found were performed in the Southeastern United States, which has unique cultural
factors that could affect intake, health status, and outcomes related to nutrition
interventions.
In summary, a number of factors have been identified in the existing literature that
are related to the outcomes of LOS, weight changes, and albumin levels among
malnourished and adequately-nourished individuals, including diagnosis, baseline
albumin, baseline BMI, diagnosis, comorbidities, age, and race. Other factors, such as
nutritional status, appear to moderate the effect of ONS on these outcomes. ONS has
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been demonstrated to be an effective intervention among patients with certain diagnoses
or conditions, such as orthopedic injuries, surgery, and pressure ulcers. Much of the
previous research has been outside the United States, and no other study has been
identified that has examined the epidemiological triad. This study will address a common
and costly diagnosis, HF, for which nutrition is an important factor in recovery, but for
which there is inadequate data on the use of ONS in daily practice in an acute care
facility. In addition, this study uniquely addresses the population of HF patients in an
acute care setting in the southeastern United States. The retrospective approach,
evaluating outcomes for persons on ONS with a comparison group who did not receive
ONS, will capture the results of ONS use in the daily practice of a hospital, and help
identify whether routine ONS prescription may be cost-effective and of tangible benefit
to patients.
The following chapter provides details of the research design and methodology to
address the research questions presented earlier, by evaluating the relationship between
ONS and the outcomes of changes in serum albumin, changes in weight, and LOS, and
the effects of the following covariates: baseline (initial) BMI, initial serum albumin level,
BNP levels, age, race, gender, CCI, payer, planned discharge destination, diagnosis of
malnutrition, nutrition risk screening score, RD consultation, location in hospital, and
season of year of admission.
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Chapter 3: Research Method
Introduction
This study sought to provide further insight into whether intervention with ONS is
related to improved nutrition outcomes and hospital outcomes in hospitalized patients. As
mentioned previously, a manufacturer of one ONS in the United States has recommended
routine ONS use for patients who meet certain criteria in hospitals, citing evidence that
the use of ONS in hospitals may be an effective and efficient way to improve patient and
hospital outcomes, reduce LOS, and reduce readmission rates (Alliance to Advance
Patient Nutrition, 2013; Abbott Laboratories, 2014). At the same time, hospitals are under
pressure to improve patient outcomes and reduce costs. Research has revealed the
benefits of ONS for orthopedic patients and for wound healing, but less information is
available on its benefits for other diagnoses. This study focused on patients with a
primary diagnosis of heart failure, because of the large number of discharges for this
diagnosis from MRMC in recent years (874 episodes or cases in 2012, and 806 cases in
2013), and because this is a diagnosis targeted by Medicare for improved outcomes. This
study examined whether there is a relationship between the provision of ONS and patient
and hospital outcomes among patients with this diagnosis in the normal day-to-day
practice of a regional medical center between July 2012 and December 2014. The
following covariates were evaluated for their effects on the relationship between ONS
and the outcomes: baseline (initial) BMI, initial serum albumin level, BNP levels, age,
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race, gender, CCI, payer, planned discharge destination, diagnosis of malnutrition, RD
consultation, location in hospital, and season of year of admission.
The remainder of this chapter includes a description of the study variables,
covariates, research design, research questions and hypotheses, sampling procedures,
description of instruments and constructs used, determination of sample size, a data
analysis plan, and description of threats to validity.
Research Design and Rationale
The independent variable (IV) in this study is nutrition intervention using ONS.
As described in the Definitions section of Chapter 2, to be counted as a nutrition
intervention using ONS, the supplement had to be ordered at least twice daily, with a
daily provision of at least 660 kcal, 58 grams carbohydrate, 26 grams protein, and 22
grams fat (at this institution, this would be provided by two servings of Ensure Plus®,
three servings of Glucerna® Therapeutic Nutrition Shakes, or two servings of Nepro®
with Carb Steady®, or a combination of these).
The dependent variables (DVs) examined included two clinical outcomes
(albumin, and weight changes); and one hospital outcome (LOS). The available data
allowed only for a final analysis of the LOS outcome. Covariates were initial BMI, age,
initial BNP, CCI, gender, location in the hospital, and time of year (by season) in which
patients were admitted. Multiple logistic regression analysis was used to evaluate the
relationship between ONS and LOS, controlling for these covariates.
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In an aspect unique to my study, the covariates cover the three aspects of the
epidemiological triad: person, place, and time. Personal characteristics include age,
gender, and body-mass index (BMI) in relation to supplement use and patient and
hospital outcomes. The place variable refers to location in the hospital by unit or floor on
which patients received the supplements. This aspect has been shown previously to have
a possible effect on my chosen outcomes (Agarwald et al., 2012). Time aspects of my
study include an evaluation of the time of year (by quarters) in which patients were
admitted, time patterns of supplement provision—such as whether it was started on
admission or later during the hospital stay--and whether the impact of supplement use on
patient and hospital outcomes is affected by such timing factors.
Selection of study cases and comparison cases. The word case in the following
descriptions will refer to an episode of hospitalization. If a patient was hospitalized more
than once during the study period, each hospitalization was considered a separate case.
From a list of all patients aged 18 or over discharged with the primary diagnoses of HF
between July 2012 and December 2014, cases were selected that met the following
criteria:


Order for ONS in an appropriate quantity to provide at least 660 kcal, 26
grams protein, and 22 grams fat daily



Order for any qualifying ONS will be active for at least 50% of hospital stay



Provider order for any oral diet other than a clear liquids diet



Patient was not on tube feeding or parenteral nutrition.
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The comparison group consisted of all discharged cases from the same time
period who met the last three criteria above, and who did not meet the criteria for cases
(i.e., on ONS).
Descriptive statistics were run for each variable, then two-way tables were run
between the LOS outcome and each IV or covariate. A multivariate logistic regression
model was developed using those IVs that showed a significant relationship with LOS in
the two-way tables, with ONS as the primary predictor. Results included analyses of
relationships between the various covariates and supplement use.
The research design was a retrospective observational design. This study was
designed as an epidemiological study rather than a clinical trial. My covariates covered
the three aspects of the epidemiological triad: person, place, and time. Quantitative
methods of analysis were used to compare outcomes for hospital patients who received
ONS with patients who did not receive supplements over a 2-year period of time. The
observational retrospective design allowed for evaluation of the effectiveness of ONS use
in a "real-world" setting that reflects day-to-day operations in an acute care setting. The
large majority of similar studies are prospective, case-control studies. While a
retrospective design does not have the strong internal validity of a randomized controlled
trial (RCT), it has the advantage of greater external validity; RCTs may not be as
generalizable to populations outside of the sample population (Hannan, 2008). This study
attempted to produce results that may apply to other hospital settings and potentially
other diagnoses.
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Additionally, because of the use of clinical data in a retrospective epidemiological
design, this study design has the advantage of being able to capture results of actual
patterns of practice by the usual clinicians who normally provide these interventions in
the acute care setting (Hannan, 2008). Therefore, this study better reflects the realities
and limits of normal hospital operations, such variation in personnel, varying approaches
by different providers, varying patient loads, and limited time to identify and assess highrisk patients. Because of the epidemiological perspective, my covariates cover the three
aspects of the epidemiological triad: person, place and time.
The hospital started using electronic medical records (EMRs) in March, 2012 (H.
Harker, personal communication, October 2, 2014). Therefore, I requested data from a
period of time during which EMRs were in place. There were no other special timerelated or resource-related constraints.
Methodology
Population
The target population consisted of inpatient cases discharged between July 2012
and December 2014, aged 18 or over, at a regional medical center, with a primary
diagnoses of HF. The sample was taken from total number of discharges for the selected
diagnoses from July 2012 through December 2013. The study was originally planned to
include the diagnoses of acute myocardial infarction (AMI), HF, pneumonia, and chronic
obstructive pulmonary disease (COPD). However, after determining sample size
according to the following information, the study was narrowed down to only one

68
diagnosis, HF. The hospital provided the following discharge numbers for 2012 and
2013, respectively: AMI – 765, 715; HF – 874, 806; Pneumonia – 557, 604; COPD –
740, 834. These numbers were used to estimate sample size.
On September 23, 2014, there were 20 patients receiving ONS in the hospital, out
of approximately 400 patients; and on September 30, 2014, there were 17 patients on
supplements out of a total of 336 patients in the hospital (J. Plassmeyer, personal
communication, September 30, 2014). These numbers provided an estimate of 5% of
patients on ONS. Extrapolating this gives the following predicted number of patients on
ONS for a 2.5-year period: AMI – 93 patients; HF – 105 patients; pneumonia – 73
patients; and COPD – 99 patients.
On September 30, 2014, out of a census of 336, 74 patients (22%) were either
NPO, on clear liquids or on tube-feedings (J. Plassmeyer, personal communication,
September 30, 2014). This percentage was used to estimate how many potential controls
would be available. As seen in table 2, because of the large number of discharges, I
determined that there will be adequate numbers of controls for a 4:1 or 3:1 ratio of
controls to cases.
For exclusions for those under 18 years of age, I used an estimate from staff at the
Children's' Hospital: There was an estimated average daily census of approximately 48
pediatric patients out of an estimated average hospital census of around 350 (M.
Narayanan, personal communication, ~September 30, 2014). These cases were excluded
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from estimates, where appropriate, since Children's Hospital data was included in
hospital data received.
Table 2
Estimated Available ONS Cases and Comparison (July 2012 – December 2014)
Diagnosis

Total
on
ONS

Available
ONS cases
lowa

Available
ONS cases
-higha

Total
Discharges

93

74

79

1750

1191

1366

105

84

89

2100

1428

1638

Pneumonia

73

58

61

1451

789

929

COPD

99

79

84

1968

1338

1474

AMI
HF

Available
comparison
cases-lowb

Available
comparison
cases -highb

Note. Numbers are after exclusions. Estimates were based on September-October 2014 percentages of patients on ONS
(~5%), and 2012-2013 discharge figures. An estimated 15-20% of patients on ONS were expected to be excluded per
exclusion criteria. Approximately 36% of patients in the comparison group for pneumonia were expected to be
excluded because they would not meet criteria (22% per hospital diet order exclusion criteria, and 14% aged under 18).
Approximately 22% of comparison cases with diagnoses of AMI, HF, and COPD were expected to be excluded based
on hospital diet order exclusion criteria alone, with no exclusion for pediatric patients since few pediatric patients were
expected to be included in the discharge data for these diagnosis which are rare in the pediatric population.
aRanges are +-5% of the estimated exclusions for the study group.
bRanges are +-5% of the estimated exclusions for the control group, as described above.

Sampling and Sampling Procedures
Because of the limited number of available cases, and the need for ONS group
sample sizes approximating the available cases, this study used data for all available
qualifying cases on ONS for at least 50% of the hospital stay, who were discharged
during the 2.5-year study period. As described above, ONS = yes cases must meet the
following criteria:
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Order for ONS in an appropriate quantity to provide at least 660 kcal, 26 grams
protein, and 22 grams fat daily



Order for any qualifying ONS will be active for at least 50% of hospital stay



Age 18 or greater on admission



Provider order for any oral diet other than a clear liquids diet for at least 50% of
their hospital stay



Patient was not on tube feeding or parenteral nutrition for more than 25% of stay.



Control cases had to meet the last three of these criteria, and not be prescribed any
ONS.
Sample size calculations. Sample size was estimated using OpenEpi (Dean,

Sullivan, & Soe, 2014). Sample size analysis was carried out for each of the three
dependent variables (albumin, weight change, and LOS), to give a power of 80%, and a
95% two-sided confidence interval (CI). The largest sample size below is 350 total cases,
with 70 in the ONS = yes group and 280 comparison (ONS = no) cases; therefore, this
will be the sample size used. The following sample sizes were estimated:
Changes in albumin levels. Lawson et al. (2003), in their study of ONS among
orthopedic surgery patients, found a drop in serum albumin of 0.28 g/L in the study
group, and 0.47 in the control group, with a mean difference of 0.19 between the study
and control groups. Botella-Carretero et al. (2010), in a study of ONS among geriatric
patients undergoing surgery for hip fracture, found significant differences in albumin
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changes between the study group and control group, but presented only graphical
information with F-statistics and p-values showing significance. Graphs appear to show
approximately 0.1-0.2 g/L differences in albumin changes between the study groups and
control groups. Therefore, I calculated sample size to detect a difference of 0.15 g/L with
SD of 0.4, resulting in an estimated sample size of 350 cases, with 70 in the study group
and 280 controls.
Weight changes. Using data from Potter et al. (2001), the difference in weight
change between the treatment group and control group was 2.8% weight improvement, as
seen by an increase of 2.0% (SD 4.5; n = 113) in the treatment group, compared to a
weight loss of 0.8% (SD 5.3; n= 121) in the control group. Therefore, I calculated sample
size for weight changes using a more conservative estimate of 2% weight change, (SDs =
4.5 and 5.3), giving an estimated sample size of 236 cases: 59 in the study group, and 177
controls. If a weight change of 2.5% is used, the sample size for the weight change
variable is 152 total: 38 in the study group, and 114 in the control group.
Changes in LOS. Somanchi et al. (2011) found an average LOS reduction of 2.6
days in those receiving a nutrition intervention with enteral and dietary management,
from 8.71 ± 11.7 days, to 6.11 ± 5.4 days. Botella-Carretero et al. (2008) found a mean
difference in LOS of approximately 2 days (~13.5 days vs. ~11.5 days) between
orthopedic surgery patients receiving ONS (SD ~6) and not receiving ONS (SD ~ 4).
Averaging these, I used a change in LOS of 2.3 days, SD = 4.7 (study group); and SD = 9
(control group). Philipson et al. (2013) found a decrease of LOS by 2.29 days, with
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standard error (SE) of 0.0657 (n = 1,160,088); however, because of the large sample size,
this SE is not comparable to my study. Their difference in LOS of 2.29 days, however, is
compatible with my estimation of 2.3 days for sample size calculations. Therefore, I
estimated a sample size for LOS differences using change of 2.3 days, with SD = 4.7 and
9. The resulting sample size was 315 total cases, 63 in the study group, and 252 cases in
the control group (total 315).
For each diagnosis studied, I would have needed to use a separate sample of 350
patients. Because of this large sample needed for significant results, and because the
largest estimated number of cases would be available from HF patients, I chose to focus
on HF patients for this study.
Procedures for Data Collection
The following de-identified raw data were requested from the hospital (because
the information will be de-identified, no informed consent was needed):
List of all cases discharged from MRMC, aged 18 or over on admission, from
July 2012 to December 2014, with a primary diagnosis of Heart Failure, or anything
within ICD-9 code 428. For each case, the following information was requested:


Date of admission



Date of discharge



Age on admission



Gender
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Race/ethnicity



All available heights (this is to help rule out potential recorded errors that may
significantly skew data, such as a recorded height of 63 inches for someone who
is 6'3" tall).



All available weights, in pounds, for each day of hospitalization (caution with
units, sometimes they have weight in pounds, sometimes in kg)



First available BMI



Albumin levels each day of hospitalization



BNP levels for each day of hospitalization



Diet orders for each day of hospital stay



All orders in the EMR for ONS, with wording (or quantity ordered daily), for
each day of hospital stay



All dietitian referrals for each day of hospitalization, with content of any
comments entered reason/trigger for each referral (such as poor intake > 3 days)



All dietitian consults for each day of hospitalization, with content of any
comments entered



List of all diagnoses and ICD-9 codes for each patient (for CCI and malnutrition
diagnosis covariate). Preferably, a yes/no column for each diagnostic code for the
CCI and for diagnosis of malnutrition
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Locations of patient (by hospital unit) by dates throughout the hospital stay,
including any transfers



Primary payer



Planned discharge destination (home, nursing home, other)



Daily fluid intake



Average daily fluid intake
Cases were selected from this data for the study group (patients on ONS) and

control group, using sample size calculation results.
Instrumentation and Operationalization of Constructs
Charlson Comorbidity Index (CCI). This is a comorbidity index with 17-19
items, weighted according to association with mortality (Degroot et al., 2003; Farley et
al., 2006). It was introduced in 1987 by Charlson, Pompei, Ales, and MacKenzie (1987).
It is intended to help provide appropriate matched controls to reflect overall severity of
illness. The relationship between the index and ONS use was demonstrated by Philipson
et al. (2013) in their large retrospective study that used billing and diagnostic data from
the Premier Perspectives Database to show the impact of ONS use on hospital outcomes.
They found a significantly higher (p < .0001) mean CCI score of 3.4 for patients using
ONS (724,027 episodes), compared to a score of 2.1 all hospitalization episodes (N =
43,244,540). As mentioned in the Definitions section, an expanded ICD-9 coding
algorithm developed by Quan et al. (2005) was used to determine CCI scores.
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Nutritional Risk Screening Tool. Nutritional screening of patients in hospitals
within 24 hours is a national standard of The Joint Commission (TJC) (Somanchi et al.,
2011), however the tools used and criteria used to determine risk vary by hospital.
Patients who are determined to be at higher risk nutritionally are then automatically
referred to a Registered Dietitian.
The nutritional screening risk score used in this study is derived from the
screening tool used at MRMC. It was developed by the dietitians at the hospital based on
recognized factors indicating a patient is at high risk for malnutrition. The tool contained
criteria used by nurses to screen patients for nutritional risk within 12 hours of admission
and during shift assessments every 12 hours. It included the following items: head/neck
cancer with chemotherapy/radiation therapy; diagnosis of malnutrition/failure to thrive;
hyperemesis gravidarium; LOS >11 days; NPO (nil per os, or nothing by mouth) or clear
liquids diet >5 days; poor oral intake of 3 or more days; stage 2-4 pressure sore, nonhealing wound, or deep tissue injury; and unplanned weight loss of >10 pounds in the
past 3 months.
If a nurse checked off any one of these items during the initial nursing assessment
or 12-hour shift assessment for a patient at any time during the hospital stay, an automatic
referral was triggered for a Registered Dietitian consultation (see definition below). See
Appendix for a screenshot of the tool used by the nurses for nutrition screening.
Data Analysis Plan
Microsoft Excel and EpiInfo were used for the analyses.
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Data cleaning. Data were reviewed for duplicate cases, clear inconsistencies, and
missing data to determine whether cases involved could be retained. Patients who were
admitted more than once in the data collection period were treated as separate cases.
Descriptive statistics were performed on each variable and graphed as needed to
determine outliers or data that is obviously erroneous, such as a weight of 2 pounds.
Selection and screening of study group cases. All cases with orders for any of
the following products were selected for the study group:


Ensure Plus®, two or more daily



Glucerna® Therapeutic Nutrition Shakes, three or more daily



Nepro® with Carb Steady®, two or more servings daily
Exclusions from study group. The following cases were excluded from the study

group:


Cases on ONS for less than 50% of LOS.



Cases with orders for parenteral or enteral nutrition at the time of ONS provision.
Selection and screening of comparison group cases. Those cases not in the

ONS group (and not excluded from it) were selected for the comparison group. The
following were excluded from the comparison group:


Cases with orders for parenteral or enteral nutrition for over 50% of the hospital
stay



Cases with NPO orders lasting for more than 50% of the hospital stay
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Research questions and hypotheses. For the following questions and
hypotheses, all participants are hospitalized patients at the study facility, and all nutrition
interventions are in relation to this population.
Research Question 1: How is the provision of ONS related to changes in albumin
levels in participants over the course of hospitalization?
H01: Changes in patients' serum albumin levels will not be significantly different
between patients receiving ONS and those not receiving ONS during the course of
hospitalization after adjusting for baseline level of body mass index, age, race, gender,
BNP levels, season of the year, location in the hospital, weight changes, initial albumin
level, CCI, RD consultation, and diagnosis of malnutrition.
Ha1: Changes in patients' serum albumin levels will be significantly different
between patients receiving ONS and those not receiving ONS during the course of
hospitalization after adjusting for baseline level of body mass index, age, race, gender,
BNP levels, season of the year, location in the hospital, weight changes, initial albumin
level, CCI, RD consultation, and diagnosis of malnutrition.
Method of measurement: t-test derived from multiple linear regression analysis to
compare mean changes in albumin levels in patients receiving ONS with those not
receiving ONS.
Research Question 2: How is the provision of ONS related to patient weight
changes during the course of hospitalization?
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H02: Changes in patients' weights will not be significantly different between
patients receiving ONS and the those not receiving ONS after adjusting for baseline level
of body mass index, age, race, gender, BNP levels, season of the year, location in the
hospital, initial albumin level, CCI, RD consultation, and diagnosis of malnutrition.
Ha2: Changes in patients' weights will be significantly different between patients
receiving ONS and the those not receiving ONS during the course of hospitalization after
adjusting for baseline level of body mass index, age, race, gender, BNP levels, season of
the year, location in the hospital, weight changes, initial albumin level, CCI, RD
consultation, and diagnosis of malnutrition.
Method of measurement: t-test derived from multiple linear regression analysis
to compare mean weight change for patients receiving ONS with those not receiving
ONS.
Research Question 3: How is the provision of ONS related to patient LOS in the
hospital?
H03: There will be no statistically significant difference in the mean LOS between
patients receiving ONS and those not receiving ONS after adjusting for baseline level of
body mass index, age, race, gender, BNP levels, season of the year, location in the
hospital, weight changes, initial albumin level, CCI, RD consultation, and diagnosis of
malnutrition.
Ha3: There will be a statistically significant difference in the mean LOS between
patients receiving ONS and those not receiving ONS after adjusting for baseline level of
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body mass index, age, race, gender, BNP levels, season of the year, location in the
hospital, weight changes, initial albumin level, CCI, RD consultation, and diagnosis of
malnutrition.
Method of Measurement: Odds ratios determined from multiple logistic
regression analysis with ONS as the main predictor, controlling for covariates above
shown to be associated with LOS through two-way tables.
Description of data analysis plan. The Data were requested in spreadsheet
format, and were provided in report format on eight Excel spreadsheets. They were
limited to patients 18 years and over on day of admission. After the data had been
cleaned and exclusions had been removed from the data set (excluded diet orders, tube
feedings, ONS less than the specified amount or time), study group cases were identified.
Using the remaining cases, a random number table was used to select at least 350
comparison cases (499 cases were used) to provide adequate power for significant results.
I performed tests to evaluate whether assumptions for multiple linear regression
analysis were met. I calculated descriptive statistics on all variables. This provided
information for further analyses, including identification of outliers and evaluation of
whether each variable is normally distributed. This included review of where the mean
and quartiles fell within the variable distributions.
I reviewed descriptive statistics for each dependent variable to determine whether
adequate data were available to keep that variable as an outcome. Unequal variances in
the LOS variable were tested using Bartlett's test in EpiInfo. This was done in univariate
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means tests. Because of the lack of normal distribution (positive skew) and unequal
variances for LOS, the assumptions for linear regression were not met for this variable.
Therefore, this DV was categorized into high and low groups and logistic regression was
used instead to test the hypothesis.
Where normal distributions were not found for continuous IVs, I transformed
them into categorical data to meet assumptions and allow appropriate statistical testing.
Because of the large number of variables, and lack of normality in many of the
distributions, I ultimately transformed all IVs into categorical data to meet assumptions
and allow appropriate statistical tests to be used.
Obvious outliers were removed if values appeared obviously erroneous. Results
from chi-square analysis in two-way tables between each IV and each DV was used to
determine which variables were significantly associated with the dependent variables.
Covariates were chosen because they had been shown in prior research, described
previously, to be related to one or more of my independent or dependent variables. These
included variables shown to be related to LOS (CCI, race, age); illness severity or LOS
(CCI, BNP levels, diagnosis of malnutrition, payer, planned discharge destination,
nutrition screening score, age, race); ONS use or decision to order ONS (BMI, RD
consultation, nutrition risk screening, diagnosis of malnutrition, weight changes, albumin
level); or nutritional risk (BMI, weight changes, albumin level), which often precipitates
an order for ONS. Location in hospital and time of year have been associated with
readmissions (Park et al., 2014) and are aspects of the epidemiological triad.
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The original plan called for three separate regression models to be evaluated; one
for albumin change, one for weight change and one for LOS. Each model would include
ONS as the main predictor, controlling for the covariates listed above. This study
ultimately only considered the LOS outcome. I evaluated whether and how much each
covariate appeared to affect this outcome, first for unadjusted relationships, then adjusted
for relevant covariates. Results are shown using odds ratios and respective confidence
intervals.
Threats to Validity
Threats to External Validity
Every hospital has its own methods of identifying patients at high risk
nutritionally; and its own policies, procedures, and customs for patient interventions.
Physicians, other providers, and dietitians all use clinical judgment and have their own
approaches. Therefore, what works well in one hospital does not necessarily work well in
another hospital or setting. However, there is also general agreement among medical
practitioners, hospitals, payers, and accreditation organizations about the need to address
poor nutrition among hospitalized patients and to improve outcomes for patients and for
the institution. The use of ONS makes the intervention I am studying very reproducible,
because of the common use of standard ONS; using the same ONS products would make
this more reproducible in other hospitals and settings.
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Threats to Internal Validity
One potential threat to internal validity was the extent to which my statistical test
assumptions are met. This was discussed above for LOS, and because assumptions for
linear regression were not met for this outcome, a change was made to logistic regression
for analysis. Other adaptions were made for other variables to improve internal validity
and are discussed in chapter. A big challenge was also being sure that I had controlled for
all relevant covariates, since most people getting ONS in a hospital tend to be sicker and
at higher risk nutritionally. To address these issues, I tried to include any covariate of
which I am aware, based on previous studies, as well as my 13 years’ experience as a
registered dietitian (RD) in the acute care setting; I also had this information reviewed by
another experienced RD.
Threats to Construct or Statistical Conclusion Validity
Threats to construct or statistical conclusion validity in this study may be found in
potential selection bias, in that patients who are found to have received ONS or nutrition
consultation are generally those patients who were considered at higher risk nutritionally
by medical or nursing staff, or identified through initial nursing assessment nutrition
screening. I sought to overcome this bias by adjusting for nutritional risk, as well as other
factors affecting supplement use--age, sex, BMI, diagnosis of malnutrition, and
comorbidity score--through multiple logistic regression analysis.
A potential threat to statistical conclusion validity was inadequate power if I had
been unable to identify enough patients on ONS after exclusion and data cleaning for an
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adequate sample size. I attempted to avoid this by using at a 2.5-year data collection
period, and excluding from the final logistic regression model any covariates that did not
show statistically significant effects on the DV. I also excluded the albumin change
outcome because of inadequate albumin data.
Another threat to statistical conclusion validity would be if statistical analyses
were performed when the assumptions for the statistical tests are not met, such as lack of
normality of the error distribution or nonlinear relationship in linear regression analysis.
These assumptions were checked to prevent this type of lack of validity, and continuous
variables were changed to categorical variables so that statistical conclusions would be
valid. Statistical conclusion validity could also be violated if there were too much
heterogeneity in the cases. Therefore, as described above, I used appropriate data
transformations or nonparametric tests when appropriate to avoid this threat to validity.
Additionally, using only a diagnosis of HF helped reduce this aspect of threat to validity.
Inaccurate data could also be a threat. In this case, I am depending on data from
the hospital. It is likely that lab tests have a high degree of validity, however, my
experience indicates that weight and height data may be less reliable, due to measurement
errors because of different instruments of measurement (bed scale versus lift or stand-up
scale), or failure of staff to follow protocol for measurement—especially a problem with
bed scales when one must only have certain items on the bed, and zero the scale when
appropriate. Values for height may also be inaccurate if they are estimates from patients
or staff. Data review and cleaning prior to analysis were performed to reduce some of this
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type of error; also it was assumed that similar rates and patterns of error were present in
the study group and comparison group.
Ethical Procedures
This proposal was approved by the Walden University IRB (IRB approval
number 12-23-14-0146221), as well as the hospital IRB before commencing the study.
The hospital IRB gave me permission to perform the study in a letter dated February 9,
2015. A HIPAA waiver of authorization and waiver of informed consent were provided.
I abided by HIPAA regulations as stipulated by the hospital, and in consultation
with the hospital’s HIPAA Officer. I requested de-identified data, but since the data came
in eight separate reports, there were common identification codes in each spreadsheet to
tie together the data for each case. After I had selected the study group and comparison
group cases and had entered all the required data onto one spreadsheet, I deleted those
identifiers from my working table before analysis. I shared this table only with my
Dissertation Committee Chair for advice and assistance during analysis. No one else had
access to the tables, and data was kept on my password-protected laptop. I spoke with the
facility HIPAA officer as needed during the process to be sure I was in compliance.
As a previous employee of the hospital (PRN from January to October, 2014; and
full-time from October 2001 until January 2014), it is possible I had seen or assessed
patients in the study, but I could not tell from the data if this were so since there were no
recognizable identifying data. While I may also have known medical practitioners who
took care of patients, I had no way of knowing who took care of any patients on the list.
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Additionally, this study was not evaluating how well the hospital or employees did a job,
but only how well a certain intervention appeared to help patients.
Summary
This study was a retrospective observational study, with quantitative analysis of
the relationship between ONS use and LOS for individual patients. I used multiple
logistic regression analysis to evaluate whether there were significant differences in
outcomes between those receiving ONS and a comparison group during the course of
hospitalization after adjusting for baseline level of body mass index, age, gender, season
of the year, location in the hospital, CCI, RD consultation, and diagnosis of malnutrition.
Inclusion of variables related to time, person, and place provided an epidemiological
approach to the effectiveness of ONS in the hospital setting for patients with a diagnosis
of heart failure. Data collection details and results will be provided in the following
chapter.
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Chapter 4: Results
Introduction
This study was intended to show whether intervention with nutrient-rich, liquid
ONS was associated with improved hospital and patient outcomes among hospitalized
patients with a primary diagnosis of HF. Odds ratios for high LOS were determined for
patients who received ONS compared to patients not receiving ONS using multiple
logistic regression analysis, while controlling for covariates known or suspected to be
associated with these outcomes. This chapter will describe the data collection, descriptive
and demographic characteristics of the sample, data analysis, and results.
The following alternate hypotheses were originally proposed:
Ha1: Changes in patients' serum albumin levels will be significantly different
between patients receiving ONS and those not receiving ONS during the course of
hospitalization after adjusting for baseline level of body mass index, age, race, gender,
BNP levels, season of the year, location in the hospital, weight changes, initial albumin
level, CCI, RD consultation, and diagnosis of malnutrition.
Ha2: Changes in patients' weights will be significantly different between patients
receiving ONS and the those not receiving ONS during the course of hospitalization after
adjusting for baseline level of body mass index, age, race, gender, BNP levels, season of
the year, location in the hospital, weight changes, initial albumin level, CCI, RD
consultation, and diagnosis of malnutrition.
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Ha3: There will be a statistically significant difference in the mean LOS between
patients receiving ONS and those not receiving ONS after adjusting for baseline level of
body mass index, age, race, gender, BNP levels, season of the year, location in the
hospital, weight changes, initial albumin level, CCI, nutrition risk screening score, RD
consultation, and diagnosis of malnutrition.
Data Collection and Cleaning
Data were provided incrementally by the hospital over a period of 4 months, in
eight separate reports, ranging from 1772–3090 cases per report. Reports included
diagnosis and ICD-9 codes; demographic data; visit dates; all diet orders and dates of
orders; dietitian referrals and consults, with reasons for consults (but not referrals), dates
and comments; all heights and weights and dates recorded; all BNP and albumin results
with dates; average daily fluid intake for each case; patient room location for each case;
and dates in each room, list of hospital units and rooms associated with those units. I
reviewed the data, clarified information, and corrected errors in consultation with the
hospital data analyst. I then retrieved data from the reports, moved them into a single
spreadsheet, and formatted them for analysis by EpiInfo. I had to copy and paste or
transfer most of the data from a variety of partial spreadsheets onto a master spreadsheet
so that information would line up properly, with one row per case. Moving and
reformatting the data was completed over a 5-month period. Data were not available on
the reports for all IVs; n for IVs ranged from 541–570.
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Because of the potential for error in the data consolidation process, I incorporated
several methods to limit the introduction of errors; I double-checked certain data during
the entry process, or incorporated other checks into my data retrieval process. For
example, when I started to enter lab data for a given case, I highlighted the case number
in blue so I would not lose track of which row I was working on. I compared admission
date to dates of lab data to be sure it fit. Since the comparison cases (ONS = no) were
randomly chosen, the search for other data required some jumping over data on other data
sheets, and I double-checked case numbers for newly entered data against admission and
discharge dates. The need to manually enter or move most of the data allowed me to
better review the actual data and identify obvious outliers or likely errors (such as large
differences or inconsistencies in heights or weights, or probable erroneous lab data such
as a BNP of 6,000 at 4 am and 0 at 5 am).
Selection of ONS Cases
Diet orders for all cases were reviewed for selection of ONS=Yes (received
supplements as defined previously), with a total of 90 cases qualifying and used in the
study. According to my sample size calculations (Chapter 3), I needed at least 70 cases in
the ONS=Yes group and 270 in the ONS=No group to give a power of 80%, and 95%
two-sided CI. Of the ONS=No cases, 499 were selected using random numbers generated
by Microsoft Excel, with the expectation that at least 20% of these might be excluded
according to criteria for exclusion. After some exclusions related to discrepancies or
problems with the data (dates of diet orders or heights and weights not within period of
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hospitalization, missing outcomes data), 481 ONS=No cases and 89 ONS=Yes cases
were retained, for a total of 570 cases.
The overall sample can be considered to be representative of the population of
interest. I used all patients who actually received ONS for most of their hospitalization in
the given time period, so I studied all subjects in this population. For those not receiving
ONS, a random sample was used so it is assumed to be representative of the population
of interest.
ONS group classification and exclusions. When the electronic medical record
system started in 2012, there was initially no way to enter frequency for supplements, so
the kitchen sent all ordered supplements three times daily (J. Plassmeyer, personal
communication, 5/1/15). When frequencies became available in the ordering system, I
noticed Glucerna® (supplement for people with diabetes) was often ordered only twice a
day, compared with three daily for some other supplements. Because this did not meet
my pre-defined criteria for ONS=Yes, these former patients were excluded.
Other Exclusions. The following other exclusions were made when a patient did
not fit clearly into either ONS=Yes or ONS=No classifications:


NPO, or on clear liquids 25-50% of stay



On ONS 12.5 - 50% of their total stay



If diets started more than a day before admission date, and LOS was < 4 days
(1/2day for LOS=1 day)
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Patient on supplements of a different type or inadequate quantities of supplement
to meet criteria
NPO days. To calculate days NPO, I focused on waking hours NPO and

considered meals missed in these calculations. So if they were NPO from midnight until
9 am, they were considered NPO only 0.2 days. . If they were NPO from midnight until 6
am, they were not considered to have missed any meals
Cases to be excluded were not given a code for ONS. I highlighting all cases to be
excluded (per above criteria); then I sorted the data by ONS vs. no ONS, to be sure that
no highlighted data were accidently coded (with a “1” or “0” in the ONS column) for
inclusion. When cases were chosen for the study, only those with ONS codes were then
included.
LOS
LOS was provided by the hospital to the nearest day, so I calculated exact LOS
from the admission and discharge dates/times. Because of the lack of normal distribution
for LOS, the assumptions for linear regression were not met for this variable. Therefore,
this DV was categorized and logistic regression was used instead.
BMIs, Weights, and Heights
BMI values. I was given a report showing all weights, heights, and hospitalcalculated BMI values obtained during a patient’s hospitalization. I used the BMI values
if the height and weight appeared valid, and recalculated it if I noticed that a questionable
height or weight had been used to determine BMI.
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Weights. I used my clinical judgment and experience as a registered dietitian in
evaluating and transferring heights and weights to the spreadsheet. For an initial weight
to be counted, it had to be within 24 hours of admission. I required final weights to be on
the day of discharge, or within the last quarter of the hospital stay. Some were
unavailable, so no values could be entered.
The report automatically converted all weights from pounds (lb.) to kilograms
(kg) (by dividing by 2.2), according to my request for weights in kg. However, I noticed
that some initial weights had actually been in kg and the conversion factor led to
erroneous weights. I was able to catch these and use the actual weight in kg (available on
the same report). If there was an extreme change between the initial weight and the next
day’s weight (such as 40 pounds), and the second day’s weight follows the trend of the
other weights, I used the second day’s weight. If a weight changed more than 1 lb. per
hour, I considered there to be a discrepancy and did not enter data that appeared to be in
error.
In some cases, the initial weight (or occasionally, the final weight) was outside
the time frame of the hospitalization LOS dates; in such cases I excluded the case unless
it was within a few hours. In such cases, I could assume that the person was admitted
through the emergency department, and if there was a significant weight discrepancy
(over 1 lb. per hour) weight change between it and the next weight, I excluded the initial
pre-admission weight and used the next weight within the LOS.
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Heights. There were also some inconsistent values for height. If height changed
over the time of the hospitalization, I used the second one. This is based on my
experience that some nurses would enter their best guess for height if the patient was
unable to talk or tell them on admission, because it was a required field for nursing
assessments in the hospital. A later height was more likely to have been obtained directly
from the patient, family, or dietitian. If some issues cannot be solved by looking at the
data (such as large jumps in height or weight), I did not enter weight data for that case.
BNP and Albumin Levels
Initial laboratory values were only used if they were within 2 days after admission
or 0.5 days before admission (assuming they were in the ED contiguous with admission,
or awaiting or anticipating admission); and final values within 2 days before discharge.
For very long stays (over 10 days, 2.5 days on either side was acceptable). For shorter
LOS, such as 3-5 days, initial value needed to be within one day of admission.
Patient Location in Hospital
The hospital reports showed locations throughout a patient’s hospitalization.
Patient location was indicated by room numbers. A separate list was provided by the
hospital showing lists of room numbers for each hospital units/floor. In cases where the
same room numbers were listed for several units, I used the most logical or normal
classification (e.g., if room 717 was listed on 7th floor and ED, I used the 7th floor
classification). Because some floors/units had too few cases, I used available information
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on the hospital unit classification to combine units into similar groups of floors/units by
function, such as intensive care units, progressive care floors, or medical-surgical floors.
When I retrieved room data, I entered initial location, location on day 2 (24-48
hours after admission), and location at discharge. Most patients entered the hospital via
the emergency department (ED), so I did not count this as the initial location unless the
patient remained there for over 6 hours (4 hours for LOS=1) after time of admission to
the hospital. While many were in the ED for a few hours prior to admission, I only used
data after admission. For patients in the Inpatient ED for over 6 hours, I listed the ED as
initial location. A review of location data showed that many patients moved within the
first 1-2 days, and the Day 2 location appeared to give a better picture of where the
patient was located for the majority of the hospital stay. Therefore, I used this location for
the final analysis.
Discharge Destination
Discharge destination was listed on the same row as patient ID, so could easily be
included in my table. I did not have to do any editing but was able to copy them onto the
master spreadsheet along with age, ethnicity, gender, and dates of admission and
discharge. There were 11 different discharge destinations listed for my sample. Some
categories only had one or two cases so had to be combined with others. I combined most
of those with very low frequencies into the Other category. This included Hospice Home,
Hospice Medical Facility, Left Against Medical Advice, Other Death, Other Hospital,
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and Speciality Hospital/Center. Intermediate Care Facility discharges were added to the
Rehab.
Dietitian Consults and Referrals
I received a list showing date and time of all referrals and consults to the RD, and
reason for consult if listed. However, no reasons for referrals were provided; therefore, I
was unable to determine nutrition risk scores (as described in Chapter 3, under
Instrumentation and Operationalization of Constructs). Many patients who received
consults also received referrals. Because of the small number of cases with referrals
(11.5%), and overlapping referral and consult data, I combined the referrals and consults
into one RD Consult category. Further details are provided in the data analysis section.
The RD referral lists showed that 88.5% of cases (483) had no RD referrals; 3.9% had
one referral; and 2.6% had 2 referrals; the remaining 5.1% had 3 or more referrals.
59.9% of cases had no consults, 37.4% had one consult, 1.8% had two or more.
I double-checked 70% of the RD consultations and referral data after entering
them, and checked the other as I went along, with a final spot-check. I found and
corrected two discrepancies in all those I double-checked.
Diagnosis of Malnutrition
There were not enough cases with this diagnosis to analyze its contribution (only
2.8% of all cases). I considered adding the diagnosis of Failure to Thrive, Adult (FTT).
This latter diagnosis may have various causes, not all of which are malnutrition; but it
often indicates malnutrition. However, a quick count of FTT diagnoses showed 50 out of
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3090 cases with this diagnosis, which—if proportional to the number of cases in my
sample—would have only given 9-10 cases with this diagnosis out of the 570 cases in my
sample. This would not be enough to provide the power I would need to show significant
contributions to my analysis.
Charlson Comorbidity Index (CCI) Scoring
As mentioned in the definitions and methodology sections, I used expanded ICD9 codes provided by Quan et al. (2005) in determining CCI coding. Because Quan et al.
did not show points for categories displayed, I used additional guidance for points from
Charlson et al. (2008), Halfon et al. (2002); Rohrer, Adamson, et al. (2008); and Rohrer,
Rasmussen, & Adamson (2008). If there was an inconsistency among these references for
point values, I used those from Halfon et al. This included 1 point for mild liver disease
(including viral hepatitis), 3 for severe liver disease; 2 points for moderate to severe renal
disease, no points for mild renal disease; but 1 point for the general code of 585.9 (CKD,
NOS, unspecified) since there was no guidance available for it. One exception was that I
applied updated ICD-9 codes for pulmonary disease (http://www.icd9data.com/2014/),
developed after the publication by Halfon et al. These diagnoses were all given 1 point
for pulmonary disease.
Data Accuracy for Spreadsheet Entries
To improve accuracy of my copying of locations to my main spreadsheet (since
the process was very time-consuming, I could not –in the interest of completing my

96
dissertation—redo every entry to ensure accuracy, so I used the following checks and
balances to minimize errors:


Highlighted lines on the page of locations when I started to work on each one, to
prevent using data from the wrong line or accidently using data from a previous
entry



Checked admission dates and discharge dates against location dates to be sure
they synced; in some cases there were wrong location dates not within the time of
a patient’s hospital stay. In these situations, the cases had to be removed from the
list.



Frequent scrutinizing of data to be sure dates and times and location sequences
“made sense.”



After entering locations in the spreadsheet, I would go back to the source sheet
and before moving on to the next case, I would often double-check the previous
case. This provided some double-checking or spot-checking of my entries.

Initial Data Review: Variable Inclusions and Exclusions
Data were analyzed for a total of 570 cases, 89 of which were in the supplement
group (ONS = yes). The average age among the sample was 68.4 years (SD 14.2); with
56.5% male and 43.5% females. There were slightly more black than white patients-51.5% black, 47.2% white--and 1.4% were from other racial or ethnic groups.
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LOS ranged from 0.7 to 34.9 days, with a mean of 5.8 days (SD, 4.4). Its
distribution was positively skewed; the median was 4.5 days, and the mode was 1.8 days,
with the 75th percentile at 7.5 days. Because it did not meet the assumptions for linear
regression, I made it a binary categorical variable, with high LOS for cases over the 75th
percentile of 7.5 days. Logistic regression was then used instead of linear regression.
Because of the large number of variables, and lack of normality in many of the
distributions, I also transformed the other variables into categories to meet assumptions
and allow significant results for statistical tests used.
Descriptive Statistics
Demographic Characteristics
Age, gender, and ethnicity. Demographic data are displayed in Table 3. Age
ranged from 24 to 101 years of age, with an average age of 68.4 years (SD = 14.2). Fifty
percent of all cases were between 59 and 78.5 years of age. Of 570 cases, 322 (56.5%)
were male and 248 (43.5%) were female. Blacks accounted for 51.4% (N = 293) of cases,
and 47.2% (N = 269) were white. The remaining 1.4% (N = 8) were from one or more of
the following categories: American Indian, Alaskan Native, Asian, Hispanic, Native
Hawaiian/Pacific Islander, “Other”, or “Declined to Specify.” Because this group was so
small, it produced an entry in the chi-square tables below 5, and thus could not be used in
the two-way table analyses. Therefore, these cases were coded as missing values and
dropped from the table analysis.
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Payer. There were 54 different payers recorded in this sample as “primary payer”.
Some of the payers were Medicare supplements, meaning the primary payer would
actually have been Medicare. There were also a number of different Medicaid plans,
although 101 out of the 122 cases with Medicaid Plans had regular or traditional
Medicaid. Because of the small numbers in some payer groups, it was necessary to
combine many into larger groups, although I tried to avoid combining payers as much as
possible because of potential large differences in coverage terms. I separated out plans
with large numbers in the sample, such as Blue Cross Blue Shield and Care Improvement
Plus, but had to combine all other private plans. However, I combined all Medicare or
Medicare-related plans (where a Medicare supplement was listed as primary insurance)
since, by definition, supplements are the secondary insurance with Medicare as the
primary payer. I combined all Medicaid-related plans. The frequency analysis for various
payers is displayed in Table 3.
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Table 3
Demographic Characteristics on Admission
Variable

Frequency

%

Under 59

134

23.5

59-68

145

25.4

69-77

141

24.7%

78 and Over

150

26.3%

Male

322

56.5%

Female

248

43.5%

Black

293

51.4%

White

269

47.2%

8

1.4%

Blue Cross Blue Shield

67

11.75%

Care Improvement Plus

56

9.82%

Medicaid Plans

122

21.40%

Medicare Plans

200

35.09%

Missing

41

7.19%

Other Private Insurance

47

8.25%

Self-pay

37

6.49%

Age (N = 570)

Gender (N = 570)

Ethnicity (N = 570)

Other/Not specified

Payer (N = 570)
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Clinical Data
Descriptive statistics for clinical data are displayed in Table 4.
Length of stay. Mean LOS among all cases was 5.8 days (+-4.4), with the 75%
quartile at 7.5 days. Descriptive statistics indicated that it did not have a normal
distribution, and the Bartlett’s test showed unequal variances when cross-tabulated by
ONS group, as seen in Table 3 (below). Therefore, I divided it into two categories, with
high LOS over the 75th percentile, or > 7.5 days (75% = 7.484 days). It was then
necessary to use logistic regression for the analysis instead of linear regression.
Weight changes. Weight change had originally been chosen as an outcome as an
indicator of nutritional status, since weight loss has been associated with inadequate
nutrition among hospitalized patients as described previously. It was also originally
chosen as a biomarker in the context of the general hospitalized population rather than for
heart failure patients only. However, because of the nature of HF, many patients enter the
hospital with excessive fluid weight, and lose weight over the course of hospitalization;
while others have fluctuating weights, or gain over the course of hospitalization. This
made it a difficult outcome to evaluate for my study population. The mean percent weight
change over the course of hospitalization was 2.9%. The average net weight change was 2.5 lb. (+- 8.5 lb.). Several attempts were made to categorize the percent weight changes,
using either weight gain versus weight loss, or dividing weight change at the mean
percent weight change. While percent weight change was found in two-way tables to be
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associated with some covariates, multiple logistic regression models did not show
significant relationships between percent weight change and any of the IVs, including
ONS.
BMI. Only 18 cases (3.4%) had a low BMI of less than 18.5, which was an
inadequate number for the logistic regression analysis; therefore, this was combined with
the normal BMI group (18.5-24.99) for the analysis. This new group (BMI < 25) had 154
cases (28.9%). The largest number of cases (156 cases, or 29.3% of all sample cases)
were in the overweight grouping (BMI 25-29.99); frequencies for other groups are shown
in Table 4.
Albumin levels. Initial albumin levels were only available for 271 cases. Cases
that had a final albumin as well as an initial albumin were rare; therefore, albumin change
could not be kept as a dependent variable. I attempted logistic regression for other
outcomes using initial albumin values, as well as categories (Alb < 3.30, and alb > 3.31),
however it did not make a meaningful contribution to the logistic regression model, and
therefore was not included in the final model.
BNP. Mean initial BNP ranged from 0 to 260,000 pg/ml. The mean value was
15,966 pg/ml; however, the standard deviation (30,561) was too large to give usable
information for this variable in the logistic regression model. I tried putting it into
categories split at the median (7,090 pg/ml), or just over the 75th percentile (14,550), but
these categories did not provide useful contributions to the logistics equation.
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Dietitian consults and referrals. The RD referral and consult lists showed that
88.5% of cases (483) had no RD referrals; 3.9% had one referral; and 2.6% had 2
referrals; the remaining 5.1% had 3 or more referrals. For dietitian consults, 59.9% of
cases had no consults, 37.4% had one consult, and 1.8% had two or more consults. As
mentioned in the Data Collection section above, some patients who received consults also
received referrals. Because of the small number of cases with referrals (11.5%), and
overlapping referral and consult data, I combined the referrals and consults into one RD
Consult category. There were 546 cases with referral or consult data for the combined
category. Most (53.5%) had neither an RD consult nor referral; 35.4% had one referral or
consult; and 11.2% had two or more.
Diagnosis of malnutrition. Only 2.8% (15 patients) had a diagnosis of
malnutrition, an inadequate number to allow for significant results in the analysis.
Therefore, this variable could not be used in the analysis.
CCI Scores. All cases had at least a score of 1 for the HF diagnosis. Nearly onefourth (23.9%) had scores of 1-2; 20.5% had a score of 3; 37.4% had scores of 4 or 5;
13.5% had scores of 6 or more, and 4.7% of cases were missing scores. When I ran the
initial frequencies and multiple logistic analysis models, there were 27 cases with missing
CCI values. The resulting multiple logistic regression data showed an odds ratio of 10.4,
and a very high CI of 333 (p = 0.184). Therefore, imputation was used to reclassify the
missing values into the highest CCI category of CCI = 3-4, which initially had 213 cases,
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or 37.4% of the cases out of the five CCI categories. This imputation brought the total to
240 cases in this category, or 42.11% of all cases.
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Table 4
Descriptive Statistics - Clinical Information
Variable

Frequency

%

Yes

89

15.61%

No

481

84.39%

15,000 pg/ml or less

348

76.82%

Over 15,000 pg/ml

105

23.18%

< 3.3 g/dL

79

29.15%

> 3.3 g/dL

192

70.85%

No

526

97.23%

Yes

15

2.77%

0

292

53.48%

1

193

35.35%

2 or more

61

11.17%

1-2

136

23.86%

3

117

20.53%

4-5

213

37.37%

6 or more

77

13.51%

Missing

27

4.74%

ONS (N = 570)

Initial BNP (N = 543)

Initial Albumin (N = 271)

Diagnosis of Malnutrition (N = 541)

Number of RD Consultations/Referrals (N = 546)

Charlson Comorbidity Index Scores (N=570)

(table continues)
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Variable

Frequency

%

154

28.90%

<18.5a

18

3.38%

18.5-24.99a

136

25.52%

25-29.99

156

29.27%

30-34.99

86

16.14%

35-39.99

63

11.82%

40 or more

74

13.88%

BMI (N =570)
<25a

aThe

number of cases in the lowest BMI group (< 18.5) was too small to complete the regression analysis with this
group, so it was combined with the next group (18.5-24.99) for the analysis.

Time and Place Data
Descriptive statistics for time and place data are shown in Table 5.
Discharge destination. Out of 570 patients, 60.1% were discharged home, 16.0%
were discharged to home health, 7.9% to long-term care facilities, 4.4% to an inpatient
rehabilitation facility, 5.4% to other destinations (including unknown, death, against
medical advice), and 5.4% were missing discharge information.
Season of admission (time variable). The season with the highest number of
admissions was fall (179 admissions, or 31.4% of yearly admissions), while the lowest
number of admissions (97, or 17.0%) was in the summer. Spring and winter had similar
numbers of admissions: There were 148 (26.0%) in the spring, and 146 (25.6%) in the
winter.
Hospital location. More patients (112, or 19.7%) were located on the 3rd floor
(cardiac floor) than any other hospital unit. There were 61 patients (10.7%) in the
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Coronary Care Unit on day 2, and 52 (9.1%) in the Heart and Vascular Progressive care
(cardiac) unit. The 5th, 6th, and 7th floors together held 48 patients (8.4%), while the 10th
floor had 46 patients (8.1%). There were less than 40 patients on each of the other floor
classifications, including 8 North (39 patients), other progressive care or step-down units
(33 patients altogether), Medical Progressive Care/Cardiac area (32 patients), 8 South and
11th floor (31 patients combined), and 4th floor (renal floor, 26 patients).
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Table 5
Descriptive Statistics - Time and Place Variables
Sample Characteristic

Frequency

%

Home

347

60.88%

Home Health

91

15.96%

LTC

45

7.89%

Missing

31

5.44%

Other

31

5.44%

Rehab

25

4.39%

Fall

179

31.40%

Spring

148

25.96%

Summer

97

17.02%

Winter

146

25.61%

10th Floor

46

8.07%

8S or 11th Floor

31

5.44%

3rd Floor (cardiac)

112

19.65%

4th Floor (renal)

26

4.56%

5th, 6th, 7th Floors

48

8.42%

8NTH

39

6.84%

Coronary Care Unit

61

10.70%

Other ICUs – CVICU, MICU, TICU

44

7.72%

Heart and Vascular Progressive Care/Cardiac

52

9.12%

Medical Progressive Care/Cardiac

32

5.61%

Other Progressive Care/Step-Down Units

33

5.79%

Missing

46

8.07%

Discharge destination (N = 570)

Season of Admission (N = 570)

Location (N = 570)
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Data Analysis: Two-Way Tables for LOS
I analyzed the data using two-way tables, then used results to determine
appropriate variables to include in the multiple logistic regression model. Two-way table
analysis results for the IV (ONS) and LOS, as well as between each covariate and LOS,
are shown in Table 6. A high LOS (> 7.5 days) was observed among a significantly larger
proportion (55.1%) of patients on ONS, compared to 19.3% of patients not receiving
ONS (p < .001).
Demographic Characteristics and LOS
Two-way tables showing demographic characteristics in relation to LOS are
summarized in Table 6. The proportion of patients with high LOS gradually increased as
age increased, but not significantly (p = .4): For patients under 59 years (n = 134), 20.2%
had high LOS; patients aged 59-68 (n = 145), 24.1% had high LOS. For those aged 69-77
(n = 141), 26.24% had high LOS; and for those 78 and over (n= 150), 28.67% had high
LOS. (Age groups were divided approximately by quartiles).
Gender was significantly associated with high LOS (p = .003), with a greater
proportion of females (31.1%) having a high LOS, compared to males (20.2%). Ethnicity
was also associated with high LOS (p = .064): 28.6% of Whites (n = 269) compared with
21.8% of Blacks (n = 293 Payer did not show a significant association with high LOS (p
= .122).
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Table 6
Two-Way Table Results – High LOS and Demographic Information
Variable

High LOS (> 7.5 Days)
Yes
N

No
%

N

%

Age (years) (N = 570)

.402

Under 59

27

20.15%

107

79.85%

59-68

35

24.14%

110

75.86%

69-77

37

26.24%

104

73.76%

8 and Over

43

28.67%

107

71.33%

.003 a

Gender (N = 570)
Male

65

20.19%

257

79.81%

Female

77

31.05%

171

68.95%

.064 a

Ethnicity (N=562)
Black

64

21.84%

229

78.16%

White

77

28.62%

192

71.38%

Payer (N = 570)

.122

Blue Cross Blue Shield

11

16.42%

56

83.58%

Care Improvement Plus

11

19.64%

45

80.36%

Medicaid Plans

40

32.79%

82

67.21%

Medicare Plans

49

24.50%

151

75.50%

Missing

7

17.07%

34

82.93%

Other Private Insurance

15

31.91%

32

68.09%

Self-pay

9

24.32%

28

75.68%

aChi-square

p-value

uncorrected two-tailed p-value.
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Clinical Information and LOS
Two-way table results for clinical information in relation to high LOS is displayed
in table 7. ONS use was significantly associated with high LOS (p < .001), with 55.1%
of patients on ONS having high LOS, compared to only 19.3% high LOS among patients
not receiving ONS. BMI classification was not significantly associated with LOS (p =
.913). More patients with high initial BNP had high LOS, but the difference was not
significant (p = .131); for BNP in the top quartile (BNP > 15,000), 33.3% had high LOS;
while 25.0 % of those with lower BNP levels (< 15,000) had high LOS. Similarly, among
the 271 patients with initial albumin levels, those with lower albumin levels appeared
more likely to have high LOS (35.4% high LOS with albumin < 3.3 g/dL; and 27.1% for
albumin >3.3), but the difference was not significant (p = .170). Diagnosis of
malnutrition was seen in only 15 patients; surprisingly, 20% of them had high LOS
compared to 25.5% of other patients (p =.631).
RD consultations were significantly and positively associated with high LOS (p <
.001; n = 546): Among those with two or more consultations, the rate of high LOS was
49.2%, more than double those with 0-1 consults: 21.2% for 1 consult and 22.3% for
those with 0 consults. CCI scores also showed a significant association with LOS (p <
.001), with noticeable increase in high LOS from 12% to 35% as CCI increased from 1 to
> 6; from 11.8% high LOS for CCI = 1-2, to 35.1% for patients with CCI > 6.
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Table 7
Two-Way Table Results for High LOS -- Clinical Information
Variable

High LOS (> 7.5 days)
Yes
N

No
%

N

p-value
%

BMI (N = 570)

0.913

<25

36

23.38%

118

76.62%

25-29.99

40

25.64%

116

74.26%

30-34.99

20

23.26%

66

76.74%

35-39.99

16

25.40%

47

74.60%

40 or more

22

29.73%

52

70.27%

Missing

8

21.62%

29

78.38%

<.001 a

ONS (N = 570)
Yes

49

55.1%

40

44.94%

No

93

19.3%

388

80.67%
0.092 a

Initial BNP (N = 453)
15,000 pg/ml or less

87

25.00%

261

75.00%

Over 15,000 pg/ml

35

33.33%

70

66.67%

0.170 a

Initial Albumin (N = 271)
< 3.3 g/dL

28

35.44%

51

64.56%

> 3.3 g/dL

52

27.08%

140

72.92%

0.631 a

Diagnosis of Malnutrition (N = 541)
No

134

25.48%

392

74.52%

Yes

3

20.0%

12

80.0%
(table continues)
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Variable

High LOS (> 7.5 days)
Yes
N

No
%

N

p-value
%

Number of RD Consultations/Referrals
(N = 546)

<.001

0

65

22.26%

227

77.74%

1

41

21.24%

152

78.76%

2 or more

30

49.18%

31

50.82%

CCI Scores (N=570)

<.001

1-2

16

11.76%

120

88.24%

3

29

24.79%

88

75.21%

4-5

70

29.17%

170

70.83%

6 or more

27

35.06%

50

64.94%

Note: CCI = Charlson Comorbidity Index
aChi-square uncorrected two-tailed p-value

Time and Place Variables in Relation to LOS
Time and place data in relation to high LOS are presented in Table 8. Discharge
destination was significantly associated with LOS (p < .001). The Other discharge
category had the highest percentage of high LOS (48.4%, possibly because it included
death and AMA); followed by discharge to long term care facilities (46.7% high LOS),
rehabilitation facilities (44.0%), discharge to home health services (33.0%), then
discharge home (17.6%). High LOS was seen in 12.9% of those with missing discharge
data.
Season of admission was not associated with LOS (p = .369), although a larger
percentage of those admitted in the summer (29.9%) had high LOS compared with
admissions in the fall (20.7%), spring (25.7%), or winter (26.0%). It was interesting that
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summer, the season with the lowest number of admissions, had the greatest frequency of
high LOS; while the season with the highest number of admissions, fall, had the lowest
LOS.
Patient location on day 2 was significantly associated with LOS (p < .001), with
the largest proportion of high LOS among patients in the coronary care unit (50.8%),
closely followed by all other intensive care units (47.7%). The heart and vascular
progressive care - cardiac units (also partly designated as non-step-down cardiac floors
during the study period) had 19.2% high LOS; medical progressive care/cardiac unit
(including some non-step-down cardiac beds) 21.9% high LOS; while all other
progressive care or step down units together had 30.3% high LOS. The 10th floor was at
17.4% high LOS; 8th or 11th floors totaled 16.1% high LOS, and 3rd floor/cardiac was
10.7% high LOS.
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Table 8
Two-Way Table Results for High LOS -- Time and Place Information
Variable

High LOS (> 7.5 days)
Yes
N

No
%

N

p-value
%

Discharge destination (N = 570)

<.001

Home

61

17.58%

286

82.42%

Home Health

30

32.97%

61

67.03%

LTC

21

46.67%

24

53.33%

Rehab

11

44.00%

14

56.00%

Other

15

48.39%

16

51.61%

Missing

4

12.90%

27

87.10%

Season of Admission (N = 570)

.369

Fall

37

20.67%

142

79.33%

Spring

38

25.68%

110

74.32%

Summer

29

29.90%

68

70.10%

Winter

38

26.03%

108

73.97%

Locationa (N = 570)

<.001

10th Floor

8

17.39%

38

82.61%

8S or 11th Floor

5

16.13%

26

83.87%

3rd Floor (cardiac)

12

10.71%

100

89.29%

4th Floor (renal)

13

50.0%

13

50.0%

5th, 6th, 7th Floors

10

20.83%

38

79.17%

8NTH

9

23.08%

30

76.92%

Coronary Care Unit

31

50.82%

30

49.18%

Other ICUs – CVICU, MICU, TICU

21

47.73%

23

52.27%

Heart and Vascular Progressive Care/Cardiac

10

19.23%

42

80.77%

Medical Progressive Care/Cardiac

7

21.88%

25

78.13%

Other Progressive Care/Step-Down Units

10

30.30%

23

69.70%

Missing

6

13.04%

40

86.96%

. aChi-square uncorrected two-tailed p-value
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Summary of Two-Way Table Results for LOS
Overall, the two-way analyses showed significant positive associations (p < .05)
between LOS and ONS use (p < .001), gender (p= .003), with a greater proportion of
males on ONS; number of RD consultations (p = .0024), with LOS increasing as RD
consults went from 0 to 1 to 2 or more; CCI (p = .0002), with larger proportions of high
LOS as CCI increased; discharge destination (p < .001), with highest proportions among
those going to LTC facilities; and hospital location (p < .001), with highest proportions in
the CCU, renal floor, other ICUs, and progressive care units. Because ethnicity was close
to the desired level of significance (p = .064), it was also considered in the logistic
regression model. BMI, initial albumin, and initial BNP did not show significant
associations with high LOS (p = .131, .170, and .631, respectively). Neither did payer,
season of admission, or age (p = .122, .369, and .402, respectively). Diagnosis of
malnutrition was not significantly associated with high LOS (p = .631), although this may
have been related to the inadequate number of cases with this diagnosis.
Data Analysis: Two-Way Tables for ONS
Two-way tables for ONS and each of the covariates showed significant
associations (p < .05) between ONS use and the following categorized variables: age
category (p < .001), with increasing rates of ONS use as age increased; gender (p =
.0087), with higher rates among females than males; and ethnicity (p = .0289), with
higher ONS use among Whites compared to Blacks. BMI category was also significantly
related to ONS use (p < .001), with higher rates of ONS use for lower BMI values: For
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BMI < 25, 25.3% of patients received ONS; for BMI 30-35, 128% of patients received
ONS, and for BMI over 40, only 6.8% of patients received ONS. High LOS (p < .001)
was also associated with ONS use, with a higher proportion of patients with high LOS
being on ONS. A significantly larger proportion of patients with low initial albumin were
on ONS (p = .0016); and a significantly greater number of patients diagnosed with
malnutrition were on ONS (p <.001). A significant association was seen between ONS
and RD consults (p < .001): As the number of RD consults increased, the proportion of
patients on ONS increased, from 9.9% of patients with no RD consults received ONS,
while 52.5% of patients with two or more consults received ONS. Discharge destination
was also significantly associated with increased ONS use (p < .001), with the largest
proportion of patients on ONS among those being discharged to long term care (42.2%)
or the Other discharge category (38.7%); and the lowest proportion (10.4%) among those
being discharged home. Significant associations were not found for initial BNP (p =
.066), CCI (p = .075), location (p = .094), payer (p = .913) or season of admission (p =
.727).
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Table 9
Two-Way Table Results for ONS– Demographic Information
Variable

ONS
Yes
N

No
%

N

p-value
%

Age (years) (N = 570)

< .001

Under 59

126

94.03%

8

5.97%

59-68

134

92.41%

11

7.59%

69-77

112

79.43%

29

20.57%

78 and Over

109

72.67%

41

27.33%
.0087a

Gender (N = 570)
Male

283

87.89%

39

12.11%

Female

198

79.84%

50

20.16%
.0289 a

Ethnicity (N=562)
Black

257

87.71%

36

12.29%

White

218

81.04%

51

18.96%

Payer (N = 570)

a

.043

Blue Cross Blue Shield

50

74.63%

17

25.37%

Care Improvement Plus

48

85.71%

8

14.29%

Medicaid Plans

101

82.79%

21

17.21%

Medicare Plans

171

85.50%

29

14.50%

Missing

39

95.12%

2

4.88%

Other Private Insurance

37

78.72%

10

21.28%

Self-pay

35

94.59%

2

5.41%

Chi-square uncorrected two-tailed p-value
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Table 10
Two-Way Table Results for ONS – Clinical Information
Variable

ONS
No
N

Yes
%

N

p-value
%

BMI (N = 541)

<.001

<25

115

74.68%

39

25.32%

25-29.99

129

82.69%

27

17.31%

30-34.99

75

87.21%

11

12.79%

35-39.99

56

88.89%

7

11.11%

40 or more

69

93.24%

5

6.76%

Missing

37

100%

0

0%

<.001 a

High LOS (N =570)
Yes

93

65.49%

49

34.51%

No

388

90.65%

40

9.35%

.066 a

Initial BNP (N = 453)
15,000 pg/ml or less

298

85.63%

50

14.37%

Over 15,000 pg/ml

82

78.10%

23

21.90%

.0016 a

Initial Albumin (N = 271)
< 3.3 g/dL

56

70.89%

23

29.11%

> 3.3 g/dL

167

86.98%

25

13.02%

<.001 a

Diagnosis of Malnutrition (N= 541)
No

447

84.98%

79

15.02%

Yes

7

46.67%

8

53.33%
(table continues)
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Variable

ONS
No
N

Yes
%

N

p-value
%

Number of RD
Consultations/Referrals (N = 546)

<.001

0

263

90.07%

29

9.93%

1

165

85.49%

28

14.51%

2 or more

29

47.54%

32

52.46%

Charlson Comorbidity Index Scores
(N=570)

a

.075

1-2

124

91.18%

12

8.82%

3

97

82.91%

20

17.09%

4-5

199

82.82%

41

17.08%

6 or more

61

79.22%

16

20.78%

Chi-square uncorrected two-tailed p-value
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Table 11
Two-Way Table Results for ONS – Time and Place Information
Variable

ONS
No
N

Yes
%

N

p-value
%

Discharge destination (N=570)

<.001

Home

311

89.63%

36

10.37%

Home Health

75

82.42%

16

17.58%

LTC

26

57.78%

19

42.22%

Rehab

19

76.00%

6

24.00%

Other

19

61.29%

12

38.71%

Missing

31

100.00%

0

0%

Season of Admission (N=570)

.727

Fall

153

85.47%

26

14.53%

Spring

127

85.81%

21

14.19%

Summer

82

84.54%

15

15.46%

Winter

119

81.51%

27

18.49%

Locationa (N=570)

.094

10th Floor

38

82.61%

8

17.39%

8S or 11th Floor

27

87.19%

4

12.90%

3rd Floor (cardiac)

100

89.29%

12

10.71%

4th Floor (renal)

20

76.92%

6

23.08%

5th, 6th, 7th Floors

40

83.33%

8

16.67%

8NTH

34

87.18%

5

12.82%

Coronary Care Unit

45

73.77%

16

26.23%

Other ICUs – CVICU, MICU, TICU

34

77.27%

10

22.73%

Heart and Vascular Progressive Care/Cardiac

45

86.54%

7

13.46%

Medical Progressive Care/Cardiac

26

81.25%

6

18.75%

Other Progressive Care/Step-Down Units

27

81.82%

6

18.18%

Missing

45

97.83%

1

2.17%
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Data Analysis: Logistic Regression Results
The final analysis concerned only an examination of the research question, “How
is the provision of ONS related to patient LOS in the hospital?” Reasons for limiting the
final analysis to this question have been discussed in previous sections (see the Clinical
Data section under Descriptive Statistics above regarding problems with weight change
and albumin change data).
Using results from two-way tables, the following variables were entered into a
logistic regression model for the high LOS outcome, with ONS as the primary predictor:
ONS, CCI, discharge destination, ethnicity, gender, location, and RD consultation.
Multiple logistic regression results for the high LOS outcome, showing IVs, ORs,
lower and upper CIs, and p-values, are shown in Table 12.
In the multiple logistic regression model, the adjusted odds of high LOS for
persons receiving ONS was 2.43 times that for patients not on ONS (p = .0037). In
comparison, before controlling for the covariates, the odds ratio of high LOS for patients
on ONS (versus no ONS) was 5.11.
The adjusted odds of high LOS were also significantly greater for patients with
higher CCI scores compared to those with the lowest scores. Compared to CCI scores of
1-2, those with a CCI score of 3 had 2.8 times the odds of high LOS (p =.011); OR for
those with a score of 4-5 was 3.34 (p < .001); and OR for patients with CCI > 6 was 3.99
(p = .001).
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Patients being discharged to a long term care facility had 2.4 times the odds of
high LOS compared to home discharge; those discharged to other destinations had an OR
of 3.97 (p = .003). This other category was mixed and the 31 patients in it included those
who left against medical advice, those going to hospice, other or specialty hospitals,
unspecified locations, and patients who died. In many of these cases, the lack of a safe
discharge option or need to await admission to another facility may have prolonged the
LOS.
While not significant, the data showed that Whites had 1.55 times the odds of
high LOS compared to Blacks (p = .07); unadjusted bivariate results also showed a higher
proportion of Whites with high LOS. Female patients had 1.56 times the odds of males
for high LOS (p = .067) in the logistic regression analysis. In comparison, the unadjusted
data showed a greater percentage of high LOS in males than females, but ONS use was
greater among females.
In regard to location, it has been mentioned previously that location on day 2 was
used for the location variable in this study, after a review of the data showed it was more
likely to be where patients spent most of their time, in contrast to initial or final locations.
Patients staying on the 4th floor (renal floor) had 4.35 times the odds of high LOS (p =
.016) compared to the 10th floor (a general medical-surgical floor); patients located in the
Coronary Care Unit had an OR of 6.06 (p < .001) compared to 10th floor patients; and
patients in other intensive care locations had an OR of 6.12 (p = .001) compared to 10th
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floor patients. These floors also had the highest proportion of patients when unadjusted
chi-square tables analysis with LOS.
Patients with two or more RD consults had an OR of 2.22 compared to those with
no RD consults (p = .0334).
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Table 12
Results of Multiple Logistic Regression for High LOS Outcome
Independent Variables

Odds
Ratioa

95% CI

p-value

Lower

Upper

1.34

4.41

.0033

ONS
Yes

2.43

No

1.0

Charlson Comorbidity Index Scores
(N = 570)
1-2

1.0

3

2.80

1.27

6.19

.011

4-5

3.34

1.64

6.83

<.001

6 or more

3.99

1.75

9.12

.001

Discharge destination (N = 570)
Home

1.0

Home health

1.69

0.90

3.18

.100

Long term care

2.40

1.12

5.14

.024

Rehab

2.88

0.96

8.63

.059

Other

3.97

1.59

9.91

.003

Missing

1.22

0.20

7.28

.827

0.97

2.48

.070

0.97

2.52

.067

Ethnicity
Black

1.0

White

1.55

Gender
Male

1.0

Female

1.56

(table continues)
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Independent Variables

Odds
Ratioa

95% CI
p-value
Lower

Upper

Location (N=570)
10th Floor

1.0

8S and 11th Floor

0.72

0.18

2.83

.64

3rd Floor (cardiac)

0.68

0.23

2.00

.48

4th Floor (renal)

4.35

1.31

14.43

.016

5th, 6th, 7th Floors

1.24

0.39

3.94

.710

8NTH

1.61

0.50

5.22

.421

Coronary Care Unit

6.06

2.19

16.79

<.001

Other ICUs – CVICU, MICU,
TICU

6.12

2.07

18.08

.001

Heart and Vascular Progressive
Care/Cardiac

1.15

0.36

3.61

.816

Missing

0.52

0.08

3.29

.491

Medical Progressive Care/Cardiac

1.33

0.37

4.74

.665

Other Progressive Care/StepDown Units

2.50

0.750

8.37

.136

Number of RD
Consultations/Referrals (N=546)
0

1.0

1

1.03

0.61

1.75

.9101

2 or more

2.22

1.06

4.65

.0334

aCross-product

odds ratio.
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Summary of Findings
The primary research question I investigated in my final analysis asked how the
provision of ONS was related to patient LOS in the hospital. My study examined the role
of demographic, clinical, time and place covariates that were shown in previous research
to be related to either LOS or ONS provision, as well as time, person, and place aspects
of the epidemiological triad. The null hypothesis, that “there will be no statistically
significant difference in the odds of high LOS between patients receiving ONS and those
not receiving ONS after adjusting for baseline level of body mass index, age, race,
gender, BNP levels, season of the year, location in the hospital, weight changes, initial
albumin level, CCI, RD consultation, and diagnosis of malnutrition,” was rejected. The
alternative hypothesis was found to be true. i.e. there was a statistically significant
difference in the odds of high LOS between patients receiving ONS and those not
receiving ONS after adjusting for the covariates.
However, the relationship between ONS use and LOS was the opposite of what
was seen in other studies reviewed that showed decreased LOS among patients receiving
ONS (Gariballa et al., 2006; Philipson et al., 2013). In this study, I found an increased
rate of high LOS (OR = 2.43; p = .0037) for patients who received ONS compared to
those who did not receive ONS, even after adjusting for a number of covariates known to
increase LOS.
Factors positively significantly associated with high LOS (p < .05) included
increased CCI (values of 3, 4-5, or CCI > 6); discharge to long term care, location on the
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4th floor (renal floor), coronary care unit, or other intensive care unit; and two or more
RD consults.
Further discussion of the relationship of ONS and these other factors to high LOS
may be found in chapter 5. In addition, chapter 5 will provide an interpretation of these
results, comparison of these results with previous research in the field; discussions of
limitations, generalizability, validity and reliability of my results; conclusions; social
change implications, and recommendations for further research.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The literature review for this study included a review of the relationship of
malnutrition to patient and hospital outcomes. Studies that used various biomarkers, such
as weight loss, albumin levels, decreased dietary intake, functional capacity, and BMI,
showed rates of malnutrition in hospitals to be anywhere from 30-69% (Agarwal et al.,
2012; Barker et al., 2011; Singh et al., 2006; Somanchi et al., 2011; Young et al., 2013).
This study was based on previous data showing that better nourished hospital
patients have better outcomes and shorter LOS, and that malnourished patients have
worse outcomes. According to research described previously, the prevention and
treatment of malnutrition in hospital patients reduces cost of care, LOS, readmission
rates, mortality, and complication rates among patients (Correia & Waitzberg, 2003;
Somanchi, et al., 2011; Rasheed & Woods, 2013, Tappenden et al., 2013).
Aziz et al. (2011) found a significant association between LOS and lower
nutrition risk scores among HF patients, using a risk score derived from albumin levels
and weight changes. ONS use is one intervention used in treating or preventing
malnutrition; but while previous evidence had shown benefits of ONS on patient
outcomes and LOS, no conclusive studies were found that analyzed such outcomes
exclusively for heart failure patients. The only one I found that examined outcomes for
HF patients receiving ONS was a very small study by Rozentryt et al. (2010), in which
the authors found improvements in weight and quality of life among cachectic HF
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patients receiving ONS, but the sample size was too small for results to be conclusive,
and LOS was not a measured outcome.
This study sought to provide further insight into whether intervention with ONS is
related to patient and hospital outcomes in hospitalized patients with HF, and the nature
of that relationship, while controlling for and evaluating the effects of covariates known
to affect nutritional status and LOS. As discussed in Chapter 4, I examined only the
outcome of LOS in this study because the data would not support analysis of clinical
outcomes at this time. This study was unique in that the retrospective design better
represented normal day-to-day hospital operations and included the perspective of the
epidemiological triad.
I performed bivariate analysis using chi-square tests to determine whether there
were significant associations between LOS and each covariate, as well as between ONS
use and each covariate. Covariates evaluated included baseline BMI, age, race, gender,
initial BNP, season of the year of admission, location in the hospital, initial albumin
level, CCI, RD consultation, and diagnosis of malnutrition.
Results for two-way tables for ONS and each of the covariates are described in
detail in Chapter 4. In summary, these results showed significant associations (p < .05)
between ONS use and the following categorized variables: age category (p < .001);
gender (p = .0087); ethnicity (p = .0289); BMI (p < .001); high LOS (p < .001); initial
albumin (p = .0016); diagnosis of malnutrition (p <.001); number of RD consults (p <
.001); and discharge destination (p < .001). The following were related to higher ONS
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use: greater age, female gender, White ethnicity, lower BMI, higher LOS, low albumin,
diagnosis of malnutrition, and receiving RD consultation. Significant associations were
not found for initial BNP (p = .066), CCI (p = .075), location (p = .094), payer (p = .913)
or season of admission (p = .727).
In bivariate tests between covariates and the LOS outcome, the following were
significantly (p < .05) associated with high LOS: ONS use (p < .001), gender (p = .003),
RD consults, CCI of 3, 4-5, or > 6 (p <.001), discharge destination (p <.001), and location
(p <.001). Using these results, a multiple logistic regression model was developed to
evaluate LOS and the influence of each of these covariates while controlling for other
variables. Ethnicity (p = .064 in the two-way tables) was also included in the model.
In the multiple logistic regression model, the adjusted odds of high LOS for
persons receiving ONS was 2.43 times that for patients not on ONS (p = .0037). This was
a reduction in OR from 5.11 (p < .001) in the unadjusted bivariate analysis between ONS
and high LOS. However, the final OR showing an increased odds of high LOS was the
opposite of the relationship shown in other studies reviewed, which had shown reductions
in LOS with ONS use. A randomized, placebo-controlled study by Gariballa et al. (2006)
and a large retrospective study by Philipson et al. (2013) both reported reduced adjusted
LOS among patients who received ONS compared to those who did not receive ONS.
Gariballa et al. (2006) found LOS among acutely ill elderly patients to be reduced by a
mean of 0.7 days, from 10.1 days among patients not receiving ONS to 9.4 days among
matched patients receiving ONS. Patients on ONS in the study by Philipson et al. (2013),
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which used only administrative data, tended to be older and sicker than a matched nonONS comparison group, but had shorter adjusted LOS by 21%, or 2.3 days on average
(95% CI [-2.4, -2.2] versus the comparison group—8.7 versus 11.0 adjusted days. While
there were clear differences between these studies and mine, the magnitude of the OR for
my study—nearly 2 ½ times the odds of high LOS for ONS recipients--was surprising.
For the covariates in the regression model, CCI, discharge destination, hospital
location, and RD consultations had significant results in relation to adjusted LOS. The
adjusted odds of high LOS were significantly greater for patients with higher CCI scores
compared to those with the lowest scores. Compared to CCI scores of 1-2, those with a
CCI score of 3 had an OR of 2.8 for high LOS (p =.011); OR for those with a score of 4-5
was 3.34 (p < .001); and OR for patients with CCI > 6 was 3.99 (p = .001).
Patients being discharged to a long term care facility had 2.4 times the odds of
high LOS compared to home discharge; those discharged to other locations had an OR of
3.97 (p = .003). This other location category was mixed and the 31 patients in it included
those who left against medical advice; as well as those discharged to hospice, other or
specialty hospitals, unspecified locations, and patients who died. In many of these cases,
the lack of a safe discharge option or need to await admission to another facility may
have prolonged the LOS.
While not significant, the data showed that White patients had 1.55 times the odds
of high LOS compared to Black patients (p = .07). Unadjusted bivariate results showed
ethnicity to be significantly associated with LOS (p = .003); Whites had a higher rate of
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high LOS (28.6%) compared to Blacks (21.8%). Also not significant, but noteworthy in
the results: Female patients had 1.56 times the odds of males for high LOS (p = .067) in
the logistic regression analysis. The unadjusted bivariate analysis showed 31.1% of
females had high LOS, compared to 21.2% of males, and ONS use was also greater
among females.
Patients staying on the 4th floor (renal floor) had 4.35 times the odds of high LOS
(p = .016) compared to the 10th floor (a general medical-surgical floor); patients located
in the Coronary Care Unit had an OR of 6.06 (p < .001) compared to 10th floor patients;
and patients in other intensive care locations had an OR of 6.12 (p = .001) compared to
10th floor patients. These floors also had the highest proportion of patients with high LOS
in unadjusted chi-square tables analysis. Patients with two or more RD consults had an
OR of 2.22 compared to those with no RD consults (p = .0334).
Interpretation of the Findings
The information cited in my literature review regarding proportions of
malnourished patients in hospitals suggest that 30-55% of patients in acute care hospitals
worldwide are malnourished (Agarwal et al., 2012; Barker et al., 2011; Singh et al., 2006;
Somanchi et al., 2011). I was unable to evaluate malnutrition or nutritional status like the
cited studies because the combined data supporting this classification—including weight
loss, decreased dietary intake, albumin levels, decreased functional capacity, and BMI-was not available for most patients. I attempted to include albumin, weight loss, and
BMI, but insufficient or questionable data in some cases did not support the analysis for
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all these indicators. For example, there were not enough patients for the chi-square table
in the low or underweight BMI category (BMI < 18.5) used to indicate poor nutrition;
therefore, I had to combine this category with the normal BMI category of 18.5-24.99.
Initial albumin levels were only available on 271, or 48% of cases. There were a number
of unusually large weight fluctuations, and patients moved around, rendering many
weights or weight changes somewhat questionable, and giving too large variances to use
in the logistic model. Therefore, I could not classify patients as malnourished in the same
way these studies did, but was able to evaluate other indicators generally associated with
poor nutrition or poor outcomes, and controlled for these in order to give a valid
comparison group. Only 2.8% of patients in this study had actual ICD-9 diagnoses of
malnutrition. The diagnosis of failure to thrive (FTT) may have been used instead of this
in some cases, but this diagnosis encompasses more than just malnutrition; malnutrition
is only one cause of FTT. Additionally, only an estimated 1.7% of patients in my sample
had this diagnosis. Malnutrition is one major reason for RD consultation, especially when
triggered by nursing assessments, but there were other reasons that RDs were consulted
to see patients.
Because of the abundance of previous research showing proportions of
malnourished patients ranging generally from 30-55%, I might assume that this
hospitalized population had similar proportions of malnourished patients, or at least 30%.
With this in mind, ONS in my study could have been assumed to have been treating some
malnourished patients, and thus one might expect improved outcomes in the
malnourished population.
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In this study, however, the rate of high LOS was significantly greater for patients
on ONS, with 2.43 times the odds of high LOS among patients receiving ONS compared
to those not receiving it. The two-way tables between ONS and various covariates show
that ONS use was associated in the expected directions with age, low albumin, RD
consults, BMI, discharge destination, and diagnosis of malnutrition. Therefore, by
considering these factors in the analysis with LOS, I was able to control for factors
related to malnutrition that affected LOS. I also controlled for other variables, such as
discharge destination and other variables related to severity of illness. Yet ONS use was
still clearly associated with much greater odds for high LOS; and despite known benefits
of ONS, its inclusion in patients’ dietary provisions did not overcome the other factors
that lead to longer LOS in these patients.
I tried in this study to evaluate ONS use from different perspectives: I used an
epidemiological triad approach that included time, place, and person, to add an additional
dimension to my study. This also helped ensure that I did not miss unexpected factors
related to patient care or patient volume in different locations in the hospital or at
different times of the year. I did find that location in the hospital was significantly related
to high LOS, especially when patients were in intensive care units or the renal unit. It was
not surprising that patients in higher-acuity units had greater proportions of high LOS,
and I controlled for this factor in the logistic model. Season did not seem to ultimately
affect my findings, although I observed that the season with the lowest number of
admissions, spring, had the greatest frequency of high LOS; while the season with the
highest number of admissions, fall, had the lowest LOS.

135
This study gave further insight also into other variables associated with high LOS,
including CCI, discharge destination, location in hospital, and RD consultations. Most of
these are related to severity of illness in some way. CCI by definition is measuring
severity of illness; many RD consults are on patients who are eating poorly or who need
diet education; and location in the hospital reflects need for special care related to
medical condition.
Hospitals have a limited amount of control over discharge destination and its
effect on LOS. They often must wait for a nursing home bed to become available; so
while a patient may be ready for discharge to a lower level of care, there is no available
discharge destination and the patient must be held in the hospital longer than needed.
Limitations of the Study
One of the disappointing aspects of my study was inability to use weight change
or albumin change as outcomes. Thus, only one outcome, LOS, could be examined.
Results for this study were dependent on the accuracy of the data provided. I
assumed most of it was accurate, but there were opportunities for errors—such as in
anthropometric measurements. Because it was a retrospective study, certain
measurements could not be mandated before collecting the data; therefore, not all desired
data were available. For some variables, there were several choices as to which values to
use; I had to make the best judgment on which was the most accurate choice. This was
true for initial weight, albumin, BNP, and location, and my criteria for choice of values
was discussed in the data analysis section. I also had to make some judgments as I
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assigned CCI values, because of changes in ICD-9 codes over the years. The CCI may
not be as valid in indicating severity of illness as it was 10-20 years ago because of
changes in understanding of the impact of certain conditions. Some are not as impactful
on health outcomes, because of significant advances in treatments and outcomes, such as
HIV/AIDS, which had a score of 6. Other conditions which not included in earlier CCI
scoring keys are recognized to have a greater impact on outcomes. These include
hypertension, depression, use of warfarin, skin ulcers/cellulitis, wounds, and
malnutrition. The first four of these were added by Charlson et al. (2008) in a study that
adapted the CCI to predict yearly costs of chronic disease among patients in a primary
care setting. However, I did not this adaptation when I started my analysis since the focus
of that study was on primary care patients and limited to chronic disease costs. It is
possible that my use of CCI and its inclusion in the regression model might have yielded
different results if I had used this adaptation.
There were some assumptions involved with the ONS variable. One is that the
supplement was actually consumed by the patient. The data did not show whether or how
much of the ordered ONS was consumed, nor whether it was actually given to the patient.
My clinical experience indicated that supplements are not always consumed. An order for
the product may have been discontinued if the patient was not drinking it, but not always.
At times, in my experience as a registered dietitian at the hospital, an ordered supplement
was not sent to the patient because of a shortage of the supplement, shortage of the
requested flavor, or error. ONS also was ordered by a number of different health
professionals, since it could be ordered by any physician, physician extender, or
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registered dietitian. It would have been ordered for different reasons by different persons,
although in my experience, the main reasons were poor dietary intake, recent weight loss,
or low body weight, severe wounds, recent surgery, or lab values suggesting poor
nutritional status. Some professionals are much more aggressive about ordering; others
did not order it even if many of the above reasons were present.
Issues with weight—and therefore BMI values--have been discussed previously.
The main issues concern validity of the weight as representing the patient’s true weight,
since patients hospitalized with HF often have fluid retention and shifts in bodily fluids
during hospitalization. Accuracy of weights can also be an issue if the patients changed
locations frequently, was weighed on a less accurate scale, or could not be weighed on
admission (such as in the ED). In the latter case, staff would need to use the patient’s
stated weight, or estimate current weight in order to complete required fields in the EMR.
Different scales in different locations, or different weighing practices, may have resulted
in weights that varied somewhat from actual weight or from one another. The
unrecognized or unavoidable presence of various items on a bed, certain mattress covers,
blankets, patient apparel, or appliances (such as leg braces, intermittent pneumatic
compression devices for prevention of deep vein thrombosis, casts, shoes, or articles of
clothing) could affect weight. This should be minimized because hospital personnel are
trained to remove extraneous items before weighing, but errors can occasionally occur.
Since BMI value depends on weight and height, any error in weight or height could
adversely affect BMI values.
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LOS was determined based on time of admission to the hospital. If the patient
spent time awaiting a bed and/or being treated in the ED before actual hospital admission
time, this would not be considered part of the LOS. However, any such variation of this
type was assumed to be similar in the ONS = yes and ONS = no groups.
While the sample was large (N = 570), the large number of variables and small
numbers in some categories, meant that the sample size was too small to analyze the data
for all categories within all variables. This was true with discharge destination, location,
and payer, for which categories (e.g., types of payers, different hospital floors) had to be
combined. Discharge destination results were influenced by how categories were
combined, but this was unavoidable, given small numbers in some categories. For
location in the hospital, analysis by each separate unit would have been ideal, but
impossible with the small number of cases in some locations. Therefore, locations were
combined into logical groups based on the functions of various floors. However, this
could have reduced the reliability of results. The payer category was the most difficult to
put into groups, because of the large number of payers, and known variability in coverage
among different payers. I tried to combine them in the most logical groupings, but
perhaps different types of combinations would have yielded different results.
My study was also limited by missing data such as laboratory results, as well as
other missing data as noted in the results section, which may affect results.
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Recommendations
Additional research is needed on the effectiveness of this specific intervention in
the HF population, as well evaluation of other interventions to improve nutritional status
and reduce LOS. Future studies could more effectively show benefits it they could
identify whether HF patients consumed supplements received, or whether there are more
benefits if ONS provision is part of a combined intervention, similar to the design of the
study performed by Somachi et al. (2011) among malnourished patients. Also, because
other studies have shown benefits of ONS among certain populations such as elderly
patients, or conditions such as malnutrition and pressure ulcers, I would recommend that
research be done to examine whether positive benefits might be gained through ONS
provision for hospitalized HF patients who have evidence of malnutrition and/or wounds.
There may be additional factors associated with ONS use that lead to greatly
increased odds for high LOS. Investigation of potential other factors could be very
beneficial to find other interventions to reduce LOS among these patients. Other potential
research might be to consider a similar study using updated adaptation of the CCI or
some other more recent or more detailed comorbidity indicator, such as the Elixhauser
Index or a “count method,” as described by Farley et al. (2006).
Individualized approaches to help reduce LOS could also be studied for
effectiveness. For example, because of large numbers of hospitalized patients reported in
previous studies to be malnourished, more individualized attention by dietitians to such
patients, without requiring a consult, may be needed rather than only ordering
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supplements. More effective screening by nursing could help identify patients most in
need of individualized attention by dietitians. This would address nutritional issues in the
35% of ONS = yes (29 out of 89) patients who did not receive dietitian consults. For
those with discharge destinations associated with highest LOS, increased attention by
care managers and nursing staff, or other approaches could target this cause of high LOS.
Implications
Shortened LOS can benefit patients, their families, and hospitals. It can reduce
costs of hospital care, as well as provide positive social benefit to the community or
general population, as well as individuals receiving hospital care. Use of ONS and other
nutrition interventions, such as dietitian consultations, have been shown in other studies
to potentially improve the healing process, prevent complications, and reduce the time
patients spend in the hospital. However, my data did not show a benefit in routine
administration of ONS in the normal hospital setting. This points to a need for further
study on when and whether ONS could be helpful in more specific cases, and implies that
investment in ONS on a routine basis may not be beneficial unless there is a special need
for them. It should also prompt researchers to examine other ways to improve LOS.
The number of patients diagnosed with malnutrition and failure to thrive in this
study was extremely low, and based on previous studies, may be greatly underdiagnosed.
Diagnosis of malnutrition was associated with ONS use, and it is possible that ONS use
could be a marker for malnutrition. Providers may want to consider whether more of their
patients may actually qualify for the diagnosis of malnutrition, especially if they believe
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the patient would benefit from ONS or other nutrition interventions. Earlier, more
frequent, and accurate identification of such patients has the potential to contribute to
positive social change by improving care for patients in special need of attention.
Improved care positively impacts not only patients, but their families. It also helps
hospitals make more effective and efficient use of health care resources.
This study has the potential to promote positive social change by providing
guidance on which variables are associated with high LOS, in order to better address
those issues and potentially reduce LOS in hospitalized patients. This study also helps
provide information on the use of ONS as an intervention. In this case, the data showed
that ONS in itself did not improve LOS among the general population of HF patients, but
was associated with 2.43 times the odds of high LOS. It is hoped that further research
would be performed to examine whether ONS use among hospitalized HF patients may
be more beneficial when certain other conditions are also present--such as malnutrition or
wounds—or among certain populations such as elderly patients.
It would be beneficial in current practice to consider more expanded approaches
to address nutritional risk factors than solely with only the use of ONS. RD consults and
further evaluation by care coordinators for HF patients; especially for patients in the
CCU, other ICUs, on the renal floor, patients destined for discharge to long-term care
facilities, and those with CCI scores of 3 or greater; may be beneficial methods to reduce
LOS.
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Conclusion
This study shows that routine ONS use alone is not sufficient to improve LOS
among the general hospitalized HF population. While I attempted to control for aspects of
hospitalization that would lead to high LOS, I did not see reduced LOS for patients on
ONS compared to those not receiving supplements. In fact, patients receiving ONS had
nearly 2 ½ times the odds of high LOS compared to those who did not receive ONS. This
suggests that patients on ONS have other issues contributing to high LOS, and ONS is
inadequate by itself to reduce LOS compared patients for whom ONS was not prescribed.
ONS has been shown to be beneficial in some cases, and is not a high-cost intervention.
But as used in normal everyday hospital operations in this medical center, the existence
of diet orders for ONS did not appear to provide measurable benefits in LOS for this
general population of HF patients.
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Nutrition Screening - Adult Admission and Shift Assessment Nutrition Screen
(screen shot from EMR)

